data_2k6l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.21 0.529 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.746 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.59 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.509 ' N ' HG23 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 15' ' ' ASP . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.47 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 23' ' ' ALA . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 ' N ' ' A' ' 42' ' ' ARG . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.528 ' N ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.74 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.429 ' O ' HG13 ' B' ' 10' ' ' VAL . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.512 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.518 ' N ' HG23 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' B' ' 15' ' ' ASP . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 45' ' ' LEU . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.518 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 23' ' ' ALA . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.525 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.431 ' O ' ' HD3' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.54 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.528 HG22 ' N ' ' B' ' 42' ' ' ARG . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.528 ' N ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.47 HD13 ' OG ' ' A' ' 17' ' ' SER . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.469 0.652 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' B' ' 15' ' ' ASP . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.673 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.744 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HD3' HG22 ' B' ' 4' ' ' VAL . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.744 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.582 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.597 HG23 ' CZ ' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.521 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.597 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.673 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.754 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG22 ' A' ' 4' ' ' VAL . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.754 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' CZ ' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.505 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.522 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.568 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.437 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.505 ' N ' ' CD2' ' B' ' 36' ' ' PHE . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.531 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 38' ' ' GLU . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.613 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 1.3 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.675 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 4' ' ' VAL . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.659 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.678 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.678 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 42' ' ' ARG . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.652 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.533 ' N ' HG12 ' B' ' 4' ' ' VAL . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.746 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.676 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.464 ' N ' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.599 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.599 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 21' ' ' PHE . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.0 OUTLIER -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.489 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.541 HG22 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.541 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.521 HG22 ' N ' ' B' ' 42' ' ' ARG . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.521 ' N ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' HG22 ' B' ' 4' ' ' VAL . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.549 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.586 HD23 ' CZ3' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 42' ' ' ARG . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 46' ' ' PHE . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.75 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.475 ' HD3' HG22 ' A' ' 4' ' ' VAL . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.466 HG21 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.508 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.548 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.548 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.469 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.469 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.586 HD23 ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.471 ' O ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.588 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.541 HG21 ' N ' ' B' ' 42' ' ' ARG . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.541 ' N ' HG21 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.634 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.258 0.552 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.525 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.675 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HB3' HG22 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.675 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' HD12 ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.61 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.66 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.66 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.4 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.542 ' OG ' HG13 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' CE2' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.512 ' N ' HG21 ' A' ' 41' ' ' VAL . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.542 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.671 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.671 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.533 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CE2' ' B' ' 36' ' ' PHE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.611 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.657 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.657 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 7.4 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.522 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.543 ' CE2' HG23 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.593 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.59 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.561 HG21 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.51 ' N ' HG21 ' B' ' 41' ' ' VAL . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.225 0.536 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.532 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.565 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.639 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.85 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' ' CD1' ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.532 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.599 ' O ' HG21 ' A' ' 41' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 38' ' ' GLU . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.534 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.437 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.638 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.849 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.849 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.511 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.529 ' HB3' ' OD2' ' B' ' 32' ' ' ASP . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.601 ' O ' HG21 ' B' ' 41' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.601 HG21 ' O ' ' B' ' 38' ' ' GLU . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.644 ' CZ3' ' CD1' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.636 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' N ' HG22 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.64 ' CD1' ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.571 HG13 HG13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 42' ' ' ARG . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.506 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' B' ' 17' ' ' SER . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.637 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.502 ' N ' HG22 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.637 ' CG2' ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.644 ' CD1' ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 37' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.571 HG13 HG13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.506 ' N ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 42' ' ' ARG . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.504 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.552 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CH2' ' CD1' ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.688 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.474 ' HB3' HG23 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.688 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 14' ' ' VAL . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.765 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.765 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.525 ' N ' HD13 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.66 ' CD1' ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.511 ' O ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.59 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 42' ' ' ARG . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.66 ' CH2' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.688 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.688 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.441 HG21 ' O ' ' B' ' 14' ' ' VAL . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.766 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.766 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.526 ' N ' HD13 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.661 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.514 ' O ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.525 HG23 ' N ' ' B' ' 42' ' ' ARG . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.525 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.222 0.534 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.677 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD3' ' CG2' ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.677 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.4 ' HB2' HD11 ' B' ' 45' ' ' LEU . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 36' ' ' PHE . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' GLY . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.876 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.658 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.679 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.534 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.679 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' B' ' 36' ' ' PHE . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.692 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 26' ' ' GLY . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CZ ' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.567 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG23 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.558 ' CG1' HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.558 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.876 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.536 ' N ' HG21 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.876 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.655 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.668 ' CH2' ' CD1' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.644 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.701 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HB3' HG23 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.701 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 14' ' ' VAL . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.79 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.577 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD1' ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.596 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.655 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.655 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.54 ' OE1' ' CG1' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.555 ' OH ' ' OH ' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.673 ' CH2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.437 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.648 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.705 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.414 ' HB3' HG23 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.705 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' VAL . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.791 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.791 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.577 ' CE ' ' HA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.668 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.597 ' N ' ' CD2' ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.654 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.603 ' CD1' ' CG1' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.555 ' OE1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.555 ' OH ' ' OH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.308 0.575 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' C ' HG12 ' A' ' 10' ' ' VAL . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG21 ' NE1' ' B' ' 6' ' ' TRP . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.664 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.664 ' CG2' ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 36' ' ' PHE . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.528 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.547 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 31' ' ' GLY . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 HG13 ' CD1' ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 34' ' ' SER . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.506 HG21 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.506 ' N ' HG21 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' ARG . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.653 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.48 ' HB3' ' OD1' ' B' ' 13' ' ' ASP . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.517 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' B' ' 11' ' ' SER . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.484 ' CB ' HD13 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.693 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.693 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.484 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.496 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' B' ' 33' ' ' LEU . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.476 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.557 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.402 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.516 ' N ' HG13 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.244 0.545 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 5' ' ' ARG . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.511 ' N ' HG11 ' A' ' 4' ' ' VAL . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.608 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' B' ' 6' ' ' TRP . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.648 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HB2' ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.557 HD13 HD11 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.554 HG13 ' CE2' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.519 ' O ' ' CD ' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' B' ' 17' ' ' SER . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.508 HG11 ' N ' ' B' ' 5' ' ' ARG . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.508 ' N ' HG11 ' B' ' 4' ' ' VAL . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 6' ' ' TRP . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.65 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.506 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.604 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 41' ' ' VAL . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.561 HG13 ' CE2' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.518 ' O ' ' CD ' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 17' ' ' SER . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.289 0.566 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.73 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' B' ' 6' ' ' TRP . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.615 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.649 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.491 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.61 ' O ' HG21 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' A' ' 6' ' ' TRP . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.617 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.451 HG21 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.646 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.536 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.646 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.508 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.492 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.613 ' O ' HG21 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.613 HG21 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.527 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.684 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' HG21 ' A' ' 8' ' ' ILE . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.447 ' HB2' HD12 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 4.1 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.509 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' N ' HG22 ' A' ' 37' ' ' ILE . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 41' ' ' VAL . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.689 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.446 ' O ' HG21 ' B' ' 8' ' ' ILE . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.552 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.493 ' O ' HG21 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.561 ' N ' HG23 ' A' ' 4' ' ' VAL . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.518 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 4.2 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.509 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.513 ' CD1' ' C ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.509 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.522 HG22 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.522 ' N ' HG22 ' B' ' 37' ' ' ILE . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 41' ' ' VAL . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.138 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' C ' ' HD3' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.4 ' O ' HG22 ' A' ' 8' ' ' ILE . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' B' ' 6' ' ' TRP . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 11' ' ' SER . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 33' ' ' LEU . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 41' ' ' VAL . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.651 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.488 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.73 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 6' ' ' TRP . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 11' ' ' SER . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.43 ' N ' HG22 ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.537 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.537 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' B' ' 33' ' ' LEU . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.452 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.566 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.509 ' N ' ' HG ' ' B' ' 33' ' ' LEU . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.52 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.535 ' N ' HG22 ' B' ' 41' ' ' VAL . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.468 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.459 ' N ' HG11 ' A' ' 4' ' ' VAL . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.667 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.667 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.579 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.452 ' N ' HG11 ' B' ' 4' ' ' VAL . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.566 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.461 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.562 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.669 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.441 ' HD3' HG23 ' A' ' 4' ' ' VAL . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.669 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.564 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.564 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.577 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.485 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.579 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.53 ' N ' HG22 ' B' ' 37' ' ' ILE . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.52 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.252 0.548 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CZ ' ' CB ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.655 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.723 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.723 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 33' ' ' LEU . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.539 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 21' ' ' PHE . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.48 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.522 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 46' ' ' PHE . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CZ ' ' CB ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.659 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.497 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.725 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.642 ' N ' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.725 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' B' ' 33' ' ' LEU . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.537 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.522 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.522 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' B' ' 21' ' ' PHE . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.427 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.655 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.481 ' O ' HG11 ' B' ' 41' ' ' VAL . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.549 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 38' ' ' GLU . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.418 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.424 HD13 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.662 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 46' ' ' PHE . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.216 0.532 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.42 ' C ' HG22 ' A' ' 8' ' ' ILE . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.685 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.685 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.627 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD12 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 35' ' ' ARG . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.822 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 42' ' ' ARG . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.697 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.598 ' CH2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.422 ' C ' HG22 ' B' ' 8' ' ' ILE . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.422 HG22 ' C ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.657 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.681 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.457 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.46 ' OD1' ' C ' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' B' ' 33' ' ' LEU . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.627 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.47 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.539 ' O ' HG23 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' B' ' 35' ' ' ARG . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.822 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.547 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 42' ' ' ARG . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.532 ' N ' HG22 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 45' ' ' LEU . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.569 ' OD1' ' ND2' ' B' ' 7' ' ' ASN . 3.1 m-20 -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.701 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.67 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.67 ' CG2' ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' N ' HD13 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 19.9 mm100 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.678 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.572 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' GLU . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 HD13 ' OG ' ' B' ' 17' ' ' SER . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.483 ' C ' ' CG ' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' CG ' ' C ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 7' ' ' ASN . 3.1 m-20 -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.441 HG23 ' C ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.668 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.668 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.407 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.708 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.708 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . 0.516 ' N ' HD13 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 20.0 mm100 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.575 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.532 HG22 ' O ' ' B' ' 38' ' ' GLU . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.489 ' C ' ' CG ' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.489 ' CG ' ' C ' ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 2' ' ' ASN . 8.5 p30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.56 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 HG23 ' C ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.621 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CD ' HG23 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.726 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.498 HG13 HG13 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 34' ' ' SER . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 42' ' ' ARG . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.492 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' B' ' 2' ' ' ASN . 8.5 p30 -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.426 HG23 ' C ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.476 ' O ' HG11 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.417 ' OG ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.733 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' SER . . . . . 0.482 ' O ' HG23 ' B' ' 37' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.471 ' CD2' HG13 ' B' ' 18' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.498 HG13 HG13 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 34' ' ' SER . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 42' ' ' ARG . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.497 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.487 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' B' ' 45' ' ' LEU . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.535 ' HB3' HG11 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.262 0.553 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.92 119.06 11.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.59 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' N ' HG23 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 15' ' ' ASP . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.47 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 23' ' ' ALA . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.537 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG22 ' N ' ' A' ' 42' ' ' ARG . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.528 ' N ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.74 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.429 ' O ' HG13 ' B' ' 10' ' ' VAL . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.637 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.512 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.518 ' N ' HG23 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' B' ' 15' ' ' ASP . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 45' ' ' LEU . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.518 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 23' ' ' ALA . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.525 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.431 ' O ' ' HD3' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.54 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.528 HG22 ' N ' ' B' ' 42' ' ' ARG . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.528 ' N ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.47 HD13 ' OG ' ' A' ' 17' ' ' SER . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.05 176.17 5.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.58 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' B' ' 15' ' ' ASP . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.673 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.744 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HD3' HG22 ' B' ' 4' ' ' VAL . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.744 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.582 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.597 HG23 ' CZ ' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.521 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.597 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' N ' HG12 ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.582 ' CZ2' ' HB2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.673 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.754 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG22 ' A' ' 4' ' ' VAL . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.754 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' CZ ' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.505 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.522 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.568 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.437 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.505 ' N ' ' CD2' ' B' ' 36' ' ' PHE . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.531 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 38' ' ' GLU . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.613 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 1.3 p-10 -140.53 136.44 32.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.15 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.675 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.535 ' N ' HG12 ' A' ' 4' ' ' VAL . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.659 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.678 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.678 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 42' ' ' ARG . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.652 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.533 ' N ' HG12 ' B' ' 4' ' ' VAL . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.746 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.676 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.464 ' N ' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.599 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.599 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 21' ' ' PHE . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.0 OUTLIER -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.489 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.541 HG22 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.541 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.521 HG22 ' N ' ' B' ' 42' ' ' ARG . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.521 ' N ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 -160.01 144.06 14.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' HG22 ' B' ' 4' ' ' VAL . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.549 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.586 HD23 ' CZ3' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 42' ' ' ARG . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 46' ' ' PHE . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.75 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.475 ' HD3' HG22 ' A' ' 4' ' ' VAL . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.466 HG21 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.508 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.548 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.548 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.469 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.469 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.586 HD23 ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.471 ' O ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.588 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.541 HG21 ' N ' ' B' ' 42' ' ' ARG . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.541 ' N ' HG21 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.634 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.75 152.12 51.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.525 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.675 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HB3' HG22 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.675 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' HD12 ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' CE2' ' A' ' 36' ' ' PHE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.61 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.66 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.66 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 7.4 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.542 ' OG ' HG13 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' CE2' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.512 ' N ' HG21 ' A' ' 41' ' ' VAL . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.542 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.671 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.671 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.533 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CE2' ' B' ' 36' ' ' PHE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.611 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.657 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.657 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 7.4 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.442 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.522 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.525 ' OG ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.543 ' CE2' HG23 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.593 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.59 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.561 HG21 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.51 ' N ' HG21 ' B' ' 41' ' ' VAL . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.131 0.491 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -160.24 132.91 6.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.532 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.639 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.639 ' CG2' ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.85 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.85 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' ' CD1' ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.532 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.599 ' O ' HG21 ' A' ' 41' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 38' ' ' GLU . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.534 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.437 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.638 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.849 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.849 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.529 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.511 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.529 ' HB3' ' OD2' ' B' ' 32' ' ' ASP . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.601 ' O ' HG21 ' B' ' 41' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.601 HG21 ' O ' ' B' ' 38' ' ' GLU . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.587 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 147.99 48.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.882 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.644 ' CZ3' ' CD1' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.636 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' N ' HG22 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.75 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.64 ' CD1' ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.571 HG13 HG13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 42' ' ' ARG . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' B' ' 17' ' ' SER . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.637 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.502 ' N ' HG22 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.637 ' CG2' ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.644 ' CD1' ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 37' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.571 HG13 HG13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.506 ' N ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 42' ' ' ARG . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.504 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.552 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.336 0.588 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.76 148.92 33.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.174 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CH2' ' CD1' ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.688 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' HB3' HG23 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.688 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 14' ' ' VAL . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.765 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.765 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.525 ' N ' HD13 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.66 ' CD1' ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.511 ' O ' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.59 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 42' ' ' ARG . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.66 ' CH2' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.688 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.688 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.441 HG21 ' O ' ' B' ' 14' ' ' VAL . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.766 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.766 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.526 ' N ' HD13 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.661 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.514 ' O ' HG21 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.525 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.525 HG23 ' N ' ' B' ' 42' ' ' ARG . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.525 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' O ' ' A' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.202 0.525 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -135.14 8.44 3.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.677 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD3' ' CG2' ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.677 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.4 ' HB2' HD11 ' B' ' 45' ' ' LEU . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' A' ' 36' ' ' PHE . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' GLY . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.876 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.876 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.658 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.679 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.534 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.679 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.541 HG22 ' CD2' ' B' ' 36' ' ' PHE . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.692 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 26' ' ' GLY . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.546 ' HB2' ' CZ ' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.567 HD11 ' N ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG23 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.558 ' CG1' HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.558 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.876 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.536 ' N ' HG21 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.876 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.655 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.249 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -122.07 139.41 53.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.668 ' CH2' ' CD1' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.644 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.701 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HB3' HG23 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.701 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 14' ' ' VAL . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.79 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.79 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.577 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD1' ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.596 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.655 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.655 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.54 ' OE1' ' CG1' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.555 ' OH ' ' OH ' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.673 ' CH2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.437 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.648 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.705 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.414 ' HB3' HG23 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.705 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' VAL . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.791 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.791 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.577 ' CE ' ' HA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.668 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.597 ' N ' ' CD2' ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.654 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.603 ' CD1' ' CG1' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.555 ' OE1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.555 ' OH ' ' OH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -140.94 121.45 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.11 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' C ' HG12 ' A' ' 10' ' ' VAL . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG21 ' NE1' ' B' ' 6' ' ' TRP . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.664 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.664 ' CG2' ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 36' ' ' PHE . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.528 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.547 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 31' ' ' GLY . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 HG13 ' CD1' ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 34' ' ' SER . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG21 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' N ' HG21 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG11 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' ARG . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.653 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.48 ' HB3' ' OD1' ' B' ' 13' ' ' ASP . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.517 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' B' ' 11' ' ' SER . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.484 ' CB ' HD13 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.693 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.693 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.484 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.496 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' B' ' 33' ' ' LEU . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.476 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.526 HD13 ' CG1' ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.557 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.402 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.516 HG13 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.516 ' N ' HG13 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -158.09 132.79 8.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 5' ' ' ARG . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.511 ' N ' HG11 ' A' ' 4' ' ' VAL . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.608 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.616 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' B' ' 6' ' ' TRP . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.648 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HB2' ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' CE2' HG13 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.557 HD13 HD11 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG13 ' CE2' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.519 ' O ' ' CD ' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' B' ' 17' ' ' SER . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.508 HG11 ' N ' ' B' ' 5' ' ' ARG . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.508 ' N ' HG11 ' B' ' 4' ' ' VAL . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.608 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 6' ' ' TRP . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.65 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.546 ' N ' ' SD ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.506 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.604 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.533 ' O ' HG23 ' B' ' 41' ' ' VAL . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.561 HG13 ' CE2' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.518 ' O ' ' CD ' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 17' ' ' SER . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.217 0.532 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 -152.29 155.61 38.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.182 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.73 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.711 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' B' ' 6' ' ' TRP . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.615 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.649 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.491 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.61 ' O ' HG21 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.582 HG21 ' CD1' ' A' ' 6' ' ' TRP . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.617 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.451 HG21 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.646 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.536 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.646 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.508 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.492 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.613 ' O ' HG21 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.613 HG21 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.527 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.253 0.549 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.84 7.9 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.684 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' HG21 ' A' ' 8' ' ' ILE . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.689 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.447 ' HB2' HD12 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 4.1 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.509 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' N ' HG22 ' A' ' 37' ' ' ILE . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 41' ' ' VAL . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.689 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.446 ' O ' HG21 ' B' ' 8' ' ' ILE . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.552 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.493 ' O ' HG21 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.561 ' N ' HG23 ' A' ' 4' ' ' VAL . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.518 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 4.2 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.509 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.513 ' CD1' ' C ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.509 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.522 HG22 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.522 ' N ' HG22 ' B' ' 37' ' ' ILE . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 41' ' ' VAL . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.45 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER -157.75 -45.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' C ' ' HD3' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.757 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.4 ' O ' HG22 ' A' ' 8' ' ' ILE . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' B' ' 6' ' ' TRP . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 11' ' ' SER . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 33' ' ' LEU . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 41' ' ' VAL . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.651 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.488 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.73 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 6' ' ' TRP . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 11' ' ' SER . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.43 ' N ' HG22 ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.537 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.537 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' B' ' 33' ' ' LEU . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.452 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.566 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.509 ' N ' ' HG ' ' B' ' 33' ' ' LEU . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.52 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.535 ' N ' HG22 ' B' ' 41' ' ' VAL . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.468 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 1' ' ' MET . 3.1 m120 -132.34 111.71 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' N ' HG11 ' A' ' 4' ' ' VAL . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.667 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.667 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.579 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 37' ' ' ILE . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.452 ' N ' HG11 ' B' ' 4' ' ' VAL . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.566 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.461 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.562 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.669 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.441 ' HD3' HG23 ' A' ' 4' ' ' VAL . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.669 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.5 HG12 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.564 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' C ' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.564 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.575 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.577 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.485 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.575 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.579 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.53 ' N ' HG22 ' B' ' 37' ' ' ILE . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.52 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -141.85 152.46 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CZ ' ' CB ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.655 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.723 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' N ' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.723 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 33' ' ' LEU . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.539 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 21' ' ' PHE . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.48 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 38' ' ' GLU . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 46' ' ' PHE . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CZ ' ' CB ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.659 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.497 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.725 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.642 ' N ' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.725 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' B' ' 33' ' ' LEU . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.537 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.522 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.522 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' B' ' 21' ' ' PHE . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.427 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.655 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.481 ' O ' HG11 ' B' ' 41' ' ' VAL . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.549 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' B' ' 38' ' ' GLU . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.418 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.424 HD13 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.662 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 46' ' ' PHE . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.275 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.38 141.0 41.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.42 ' C ' HG22 ' A' ' 8' ' ' ILE . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.685 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.685 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 33' ' ' LEU . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.627 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD12 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 35' ' ' ARG . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.822 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG22 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 42' ' ' ARG . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.697 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.598 ' CH2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.422 ' C ' HG22 ' B' ' 8' ' ' ILE . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.422 HG22 ' C ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.657 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.681 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.457 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.681 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.46 ' OD1' ' C ' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' B' ' 33' ' ' LEU . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.627 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.47 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.617 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.539 ' O ' HG23 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' B' ' 35' ' ' ARG . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.822 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.547 ' N ' HG22 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 42' ' ' ARG . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.532 ' N ' HG22 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 45' ' ' LEU . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mmm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.3 0.572 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -112.73 114.22 26.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.569 ' OD1' ' ND2' ' B' ' 7' ' ' ASN . 3.1 m-20 -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.444 HG23 ' C ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.701 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.67 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' CG2' ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' N ' HD13 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 19.9 mm100 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.678 ' HG ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.572 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' GLU . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD13 ' OG ' ' B' ' 17' ' ' SER . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.483 ' C ' ' CG ' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' CG ' ' C ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 7' ' ' ASN . 3.1 m-20 -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.441 HG23 ' C ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.668 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.668 ' CG2' ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.407 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.668 HG13 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.708 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.708 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.516 ' N ' HD13 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 20.0 mm100 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.575 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.532 HG22 ' O ' ' B' ' 38' ' ' GLU . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.489 ' C ' ' CG ' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.489 ' CG ' ' C ' ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 2' ' ' ASN . 8.5 p30 -112.14 115.76 29.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 HG23 ' C ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.621 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CD ' HG23 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.726 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.498 HG13 HG13 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 34' ' ' SER . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 42' ' ' ARG . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.492 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 45' ' ' LEU . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' B' ' 2' ' ' ASN . 8.5 p30 -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.426 HG23 ' C ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.476 ' O ' HG11 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.41 ' HD3' ' CG2' ' A' ' 4' ' ' VAL . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.417 ' OG ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.733 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' SER . . . . . 0.482 ' O ' HG23 ' B' ' 37' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.471 ' CD2' HG13 ' B' ' 18' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.498 HG13 HG13 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 34' ' ' SER . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.497 HG23 ' N ' ' B' ' 42' ' ' ARG . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.497 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.487 ' O ' ' HB1' ' B' ' 49' ' ' ALA . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' B' ' 45' ' ' LEU . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.535 ' HB3' HG11 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.21 0.529 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.83 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.6 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 11' ' ' SER . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 33' ' ' LEU . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 19' ' ' ARG . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 18' ' ' VAL . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 38' ' ' GLU . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.822 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.83 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.64 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.64 HG13 ' O ' ' B' ' 11' ' ' SER . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 1.065 HG11 HD13 ' B' ' 33' ' ' LEU . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.542 HG12 ' O ' ' B' ' 19' ' ' ARG . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.54 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.065 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 38' ' ' GLU . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.516 HD12 ' O ' ' B' ' 41' ' ' VAL . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.469 0.652 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.013 ' CZ3' HD21 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.965 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.015 HD21 ' CZ3' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 1.015 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.682 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.974 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.974 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.876 HG22 ' CE2' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.514 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.535 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.013 HD21 ' CZ3' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.876 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.784 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 1.3 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.816 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.804 HD11 ' HE3' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.649 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 7.4 mm-40 -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 HD11 HG11 ' A' ' 18' ' ' VAL . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' GLU . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.804 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.816 HD11 ' HE3' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.796 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.651 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 22' ' ' ILE . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 7.2 mm-40 -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.476 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.484 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.562 HD11 HG11 ' B' ' 18' ' ' VAL . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.492 ' O ' HG22 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 38' ' ' GLU . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' B' ' 49' ' ' ALA . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' B' ' 33' ' ' LEU . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.755 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.529 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.56 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.045 HD21 ' CH2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 1.045 ' CH2' HD21 ' A' ' 33' ' ' LEU . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.76 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.533 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.559 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.559 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.479 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.619 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.258 0.552 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.63 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.009 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.009 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.638 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.677 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 45.2 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.766 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.718 ' HA ' HD12 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.006 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.006 HG22 ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.542 ' HB3' HD22 ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.675 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.675 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 45.1 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.765 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.633 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.633 HG22 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.225 0.536 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' B' ' 12' ' ' PRO . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.544 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.067 ' O ' HG22 ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.621 ' HA ' HD12 ' B' ' 8' ' ' ILE . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.711 ' OE2' HG11 ' B' ' 14' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 42' ' ' ARG . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' A' ' 12' ' ' PRO . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.572 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.062 ' O ' HG22 ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.062 HG22 ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.545 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.784 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 8' ' ' ILE . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.7 ' OE2' HG11 ' A' ' 14' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 42' ' ' ARG . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.426 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.628 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.406 ' OXT' ' HG2' ' B' ' 51' ' ' GLU . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.005 ' CZ3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.089 ' O ' HG22 ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.089 HG22 ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 33' ' ' LEU . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.998 HD13 ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' HD12 ' B' ' 8' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' GLU . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.998 ' CZ3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 7.8 t-20 -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.093 ' O ' HG22 ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.43 ' HD3' HG23 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.093 HG22 ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' B' ' 33' ' ' LEU . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.761 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.761 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.005 HD13 ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.487 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 38' ' ' GLU . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.574 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.802 HG11 ' HB3' ' A' ' 33' ' ' LEU . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.776 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.776 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.548 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 41' ' ' VAL . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.88 ' O ' HG22 ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.88 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' B' ' 33' ' ' LEU . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.775 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.775 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.678 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA2' HD21 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.546 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.584 ' O ' HD12 ' B' ' 45' ' ' LEU . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.421 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.584 HD12 ' O ' ' B' ' 41' ' ' VAL . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.222 0.534 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' OE1' ' B' ' 38' ' ' GLU . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.862 ' O ' HG22 ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' N ' HG21 ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.952 HG11 ' OE2' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 33' ' ' LEU . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.698 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.809 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HZ ' HG12 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.933 ' OE2' HG11 ' B' ' 14' ' ' VAL . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.899 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.899 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.669 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' SD ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.423 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.761 HG12 ' OE1' ' A' ' 38' ' ' GLU . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.551 ' N ' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.933 HG11 ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' B' ' 33' ' ' LEU . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.697 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.543 ' CZ ' ' HB2' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.808 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.952 ' OE2' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.9 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.429 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.9 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.668 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.759 ' CH2' HD11 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.982 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.071 HG11 ' OE1' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.804 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 1.026 ' N ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.675 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.675 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.716 ' CD1' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 1.064 ' OE1' HG11 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.716 HG13 ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.719 ' HH ' ' HE2' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.468 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.761 ' CH2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.664 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.981 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.064 HG11 ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.806 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.806 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.022 HD23 ' N ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' SER . . . . . 1.022 ' N ' HD23 ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.672 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.672 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.713 ' CD1' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 1.071 ' OE1' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.713 HG13 ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.719 ' HE2' ' HH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.568 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.308 0.575 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.923 ' CZ2' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 14' ' ' VAL . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.16 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.16 HG22 ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.561 ' HB3' HD22 ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 33' ' ' LEU . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' A' ' 34' ' ' SER . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.731 ' CD1' HG11 ' A' ' 18' ' ' VAL . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' A' ' 32' ' ' ASP . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.612 HG13 HD13 ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 37' ' ' ILE . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' OG ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HG3' HG12 ' A' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.64 ' NE1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 37' ' ' ILE . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.82 ' HB ' HG11 ' B' ' 14' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.614 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.627 ' N ' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.638 ' OD1' HG13 ' B' ' 14' ' ' VAL . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.923 ' O ' HG23 ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.526 ' N ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.423 ' OG ' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.699 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.502 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.923 HD23 ' CZ2' ' A' ' 6' ' ' TRP . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.625 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.625 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.404 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' B' ' 46' ' ' PHE . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.515 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.515 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.244 0.545 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' B' ' 33' ' ' LEU . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 14' ' ' VAL . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.982 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.579 ' HB2' HG22 ' B' ' 8' ' ' ILE . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.686 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 37' ' ' ILE . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.688 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 45' ' ' LEU . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' A' ' 33' ' ' LEU . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 14' ' ' VAL . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.882 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.882 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.981 HG11 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.981 ' HB3' HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.826 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.4 ' N ' HG23 ' B' ' 37' ' ' ILE . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.686 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.289 0.566 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.748 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.728 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' A' ' 14' ' ' VAL . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.616 ' HB3' HD13 ' B' ' 45' ' ' LEU . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.659 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' B' ' 17' ' ' SER . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.753 ' CZ2' HD11 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' B' ' 14' ' ' VAL . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.775 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.618 ' HB3' HD22 ' A' ' 45' ' ' LEU . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.656 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.565 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.656 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.517 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.517 HG22 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 17' ' ' SER . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.556 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.408 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.408 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.725 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' B' ' 6' ' ' TRP . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.82 ' OD1' HG13 ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.82 HG13 ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.836 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 33' ' ' LEU . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 16.6 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 34' ' ' SER . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' B' ' 17' ' ' SER . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.724 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 6' ' ' TRP . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.629 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.819 ' OD1' HG13 ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.819 HG13 ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.823 ' HB3' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.85 HG11 HD22 ' B' ' 33' ' ' LEU . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.9 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.85 HD22 HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 34' ' ' SER . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.836 HD22 ' HB3' ' A' ' 17' ' ' SER . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.569 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.464 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.138 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.772 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG21 ' A' ' 14' ' ' VAL . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 14' ' ' VAL . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.773 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' B' ' 17' ' ' SER . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.666 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.507 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.745 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.578 ' HB ' HG21 ' B' ' 14' ' ' VAL . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.613 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.424 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.554 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 14' ' ' VAL . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.516 ' O ' HG22 ' B' ' 37' ' ' ILE . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.773 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.484 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.789 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.7 ' N ' HD21 ' A' ' 2' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.963 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' C ' ' OD1' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.453 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.574 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.958 HD23 ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 37' ' ' ILE . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.958 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.454 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.81 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.81 HG22 ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.57 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.513 ' C ' ' CD1' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.647 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.963 HD23 ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.683 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.579 ' O ' HG22 ' B' ' 41' ' ' VAL . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.683 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' SER . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.252 0.548 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.05 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 14' ' ' VAL . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.555 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.915 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CB ' ' CZ ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.886 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.886 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 14' ' ' VAL . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.56 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.558 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.05 HD23 ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.915 HD12 ' CD1' ' A' ' 37' ' ' ILE . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.637 HD12 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.662 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.555 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.216 0.532 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' CB ' ' OD1' ' B' ' 7' ' ' ASN . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.016 ' O ' HG22 ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.016 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.623 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.842 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.842 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.403 ' OD1' ' CB ' ' A' ' 7' ' ' ASN . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.014 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.014 HG22 ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.695 ' O ' HG23 ' B' ' 22' ' ' ILE . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.622 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.695 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.483 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.566 ' CG ' HD23 ' B' ' 33' ' ' LEU . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.853 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.626 ' O ' HG22 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 38' ' ' GLU . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.416 ' N ' HG23 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.596 ' CG ' ' ND2' ' B' ' 7' ' ' ASN . 0.5 OUTLIER -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 1.043 ' O ' HG22 ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.043 HG22 ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 84.4 mm-40 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.59 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 37' ' ' ILE . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 41' ' ' VAL . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.596 ' ND2' ' CG ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.478 HG13 HG13 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' SER . . . . . 1.035 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 1.035 HG22 ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.442 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ALA . . . . . 0.578 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 84.6 mm-40 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.591 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.513 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ILE . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.453 HD12 ' O ' ' B' ' 41' ' ' VAL . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.576 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.56 . . . . 0.0 110.288 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.06 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.974 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.471 ' OG ' HD22 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.672 ' HA ' HD12 ' B' ' 8' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 37' ' ' ILE . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' B' ' 17' ' ' SER . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' B' ' 2' ' ' ASN . 0.4 OUTLIER -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.968 HG23 ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 1.06 HD23 ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.49 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLU . . . . . 0.494 ' N ' HG23 ' B' ' 37' ' ' ILE . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.464 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' TYR . . . . . 0.616 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.471 HD22 ' OG ' ' A' ' 17' ' ' SER . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.53 ' HB3' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.262 0.553 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.92 119.06 11.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.83 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.6 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 11' ' ' SER . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 33' ' ' LEU . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 19' ' ' ARG . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 18' ' ' VAL . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 38' ' ' GLU . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.822 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.83 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.64 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.64 HG13 ' O ' ' B' ' 11' ' ' SER . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 1.065 HG11 HD13 ' B' ' 33' ' ' LEU . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.542 HG12 ' O ' ' B' ' 19' ' ' ARG . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.54 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.065 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 38' ' ' GLU . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.516 HD12 ' O ' ' B' ' 41' ' ' VAL . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.05 176.17 5.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.58 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.013 ' CZ3' HD21 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.965 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.015 HD21 ' CZ3' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 1.015 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.682 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.974 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.974 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.876 HG22 ' CE2' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.514 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.535 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.013 HD21 ' CZ3' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.876 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.784 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 1.3 p-10 -140.53 136.44 32.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.15 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.816 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.804 HD11 ' HE3' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.649 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 7.4 mm-40 -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD11 HG11 ' A' ' 18' ' ' VAL . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' GLU . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.804 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.816 HD11 ' HE3' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.796 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.651 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 22' ' ' ILE . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 7.2 mm-40 -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.476 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.484 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.562 HD11 HG11 ' B' ' 18' ' ' VAL . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.492 ' O ' HG22 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 38' ' ' GLU . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' B' ' 49' ' ' ALA . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 -160.01 144.06 14.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' B' ' 33' ' ' LEU . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.755 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.529 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.56 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.045 HD21 ' CH2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 1.045 ' CH2' HD21 ' A' ' 33' ' ' LEU . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.76 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.533 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.559 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.559 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.479 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.619 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.75 152.12 51.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.63 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.009 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.009 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.638 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.677 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 45.2 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.766 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.718 ' HA ' HD12 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.006 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.006 HG22 ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.542 ' HB3' HD22 ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.675 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.675 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 45.1 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.765 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.633 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.633 HG22 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.131 0.491 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -160.24 132.91 6.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' B' ' 12' ' ' PRO . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.544 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.067 ' O ' HG22 ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.621 ' HA ' HD12 ' B' ' 8' ' ' ILE . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.711 ' OE2' HG11 ' B' ' 14' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 42' ' ' ARG . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' A' ' 12' ' ' PRO . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.572 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.062 ' O ' HG22 ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.062 HG22 ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.545 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.784 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 8' ' ' ILE . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.7 ' OE2' HG11 ' A' ' 14' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 42' ' ' ARG . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.426 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.628 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.406 ' OXT' ' HG2' ' B' ' 51' ' ' GLU . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 147.99 48.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.882 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.005 ' CZ3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.089 ' O ' HG22 ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.089 HG22 ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 33' ' ' LEU . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.998 HD13 ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' HD12 ' B' ' 8' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' GLU . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.998 ' CZ3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 7.8 t-20 -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.093 ' O ' HG22 ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.43 ' HD3' HG23 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.093 HG22 ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' B' ' 33' ' ' LEU . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.761 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.761 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.005 HD13 ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.487 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 38' ' ' GLU . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.574 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.336 0.588 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.76 148.92 33.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.174 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.802 HG11 ' HB3' ' A' ' 33' ' ' LEU . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.776 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.776 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.548 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 41' ' ' VAL . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.88 ' O ' HG22 ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.88 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' B' ' 33' ' ' LEU . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.775 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.775 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.678 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA2' HD21 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.546 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.584 ' O ' HD12 ' B' ' 45' ' ' LEU . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.421 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.584 HD12 ' O ' ' B' ' 41' ' ' VAL . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.202 0.525 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -135.14 8.44 3.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' OE1' ' B' ' 38' ' ' GLU . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.862 ' O ' HG22 ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' N ' HG21 ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.952 HG11 ' OE2' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 33' ' ' LEU . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.698 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.809 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HZ ' HG12 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.933 ' OE2' HG11 ' B' ' 14' ' ' VAL . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.899 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.899 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.669 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' SD ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.423 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.761 HG12 ' OE1' ' A' ' 38' ' ' GLU . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.551 ' N ' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.933 HG11 ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' B' ' 33' ' ' LEU . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.697 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.543 ' CZ ' ' HB2' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.808 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.952 ' OE2' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.9 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.429 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.9 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.668 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.249 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -122.07 139.41 53.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.759 ' CH2' HD11 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.982 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.071 HG11 ' OE1' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.804 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 1.026 ' N ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.675 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.675 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.716 ' CD1' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 1.064 ' OE1' HG11 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.716 HG13 ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.719 ' HH ' ' HE2' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.468 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.761 ' CH2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.664 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.981 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.064 HG11 ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.806 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.806 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.022 HD23 ' N ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' SER . . . . . 1.022 ' N ' HD23 ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.672 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.672 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.713 ' CD1' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 1.071 ' OE1' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.713 HG13 ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.719 ' HE2' ' HH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.568 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -140.94 121.45 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.11 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.923 ' CZ2' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 14' ' ' VAL . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.16 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.16 HG22 ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.561 ' HB3' HD22 ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 33' ' ' LEU . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' A' ' 34' ' ' SER . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.731 ' CD1' HG11 ' A' ' 18' ' ' VAL . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' A' ' 32' ' ' ASP . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.612 HG13 HD13 ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 37' ' ' ILE . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' OG ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HG3' HG12 ' A' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.64 ' NE1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 37' ' ' ILE . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.82 ' HB ' HG11 ' B' ' 14' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.614 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.627 ' N ' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.638 ' OD1' HG13 ' B' ' 14' ' ' VAL . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.923 ' O ' HG23 ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.526 ' N ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.423 ' OG ' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.699 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.502 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.923 HD23 ' CZ2' ' A' ' 6' ' ' TRP . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.625 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.625 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.404 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' B' ' 46' ' ' PHE . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.515 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.515 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -158.09 132.79 8.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' B' ' 33' ' ' LEU . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 14' ' ' VAL . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.982 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.579 ' HB2' HG22 ' B' ' 8' ' ' ILE . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.686 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 37' ' ' ILE . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.688 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 45' ' ' LEU . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' A' ' 33' ' ' LEU . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 14' ' ' VAL . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.882 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.882 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.981 HG11 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.981 ' HB3' HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.826 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.4 ' N ' HG23 ' B' ' 37' ' ' ILE . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.686 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.217 0.532 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 -152.29 155.61 38.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.182 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.748 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.728 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' A' ' 14' ' ' VAL . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.616 ' HB3' HD13 ' B' ' 45' ' ' LEU . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.659 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' B' ' 17' ' ' SER . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.753 ' CZ2' HD11 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' B' ' 14' ' ' VAL . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.775 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.618 ' HB3' HD22 ' A' ' 45' ' ' LEU . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.656 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.565 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.656 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.517 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.517 HG22 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 17' ' ' SER . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.556 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.408 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.408 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.253 0.549 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.84 7.9 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.725 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' B' ' 6' ' ' TRP . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.82 ' OD1' HG13 ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.82 HG13 ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.836 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 33' ' ' LEU . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 16.6 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 34' ' ' SER . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' B' ' 17' ' ' SER . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.724 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 6' ' ' TRP . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.629 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.819 ' OD1' HG13 ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.819 HG13 ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.823 ' HB3' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.85 HG11 HD22 ' B' ' 33' ' ' LEU . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.9 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.85 HD22 HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 34' ' ' SER . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.836 HD22 ' HB3' ' A' ' 17' ' ' SER . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.569 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.464 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER -157.75 -45.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.772 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG21 ' A' ' 14' ' ' VAL . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 14' ' ' VAL . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.773 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' B' ' 17' ' ' SER . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.666 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.507 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.745 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.578 ' HB ' HG21 ' B' ' 14' ' ' VAL . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.613 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.424 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.554 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 14' ' ' VAL . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.516 ' O ' HG22 ' B' ' 37' ' ' ILE . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.773 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.484 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.789 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 1' ' ' MET . 3.1 m120 -132.34 111.71 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.963 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' C ' ' OD1' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.453 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.574 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.958 HD23 ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 37' ' ' ILE . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.958 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.454 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.81 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.81 HG22 ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.57 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.513 ' C ' ' CD1' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.647 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.963 HD23 ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.683 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.579 ' O ' HG22 ' B' ' 41' ' ' VAL . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.683 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' SER . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -141.85 152.46 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.05 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 14' ' ' VAL . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.555 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.915 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CB ' ' CZ ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.886 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.886 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 14' ' ' VAL . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.56 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.558 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.05 HD23 ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.915 HD12 ' CD1' ' A' ' 37' ' ' ILE . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.637 HD12 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.662 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.555 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.275 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.38 141.0 41.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' CB ' ' OD1' ' B' ' 7' ' ' ASN . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.016 ' O ' HG22 ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.016 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.623 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.842 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.842 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.403 ' OD1' ' CB ' ' A' ' 7' ' ' ASN . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.014 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.014 HG22 ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.695 ' O ' HG23 ' B' ' 22' ' ' ILE . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.622 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.695 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.483 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.566 ' CG ' HD23 ' B' ' 33' ' ' LEU . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.853 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.626 ' O ' HG22 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 38' ' ' GLU . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.416 ' N ' HG23 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mmm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.3 0.572 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -112.73 114.22 26.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.596 ' CG ' ' ND2' ' B' ' 7' ' ' ASN . 0.5 OUTLIER -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 1.043 ' O ' HG22 ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.043 HG22 ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 84.4 mm-40 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.59 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 37' ' ' ILE . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 41' ' ' VAL . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.596 ' ND2' ' CG ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.478 HG13 HG13 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . 1.035 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 1.035 HG22 ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.442 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.578 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 84.6 mm-40 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.591 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.513 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ILE . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.453 HD12 ' O ' ' B' ' 41' ' ' VAL . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.576 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -112.14 115.76 29.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.288 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.06 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.974 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.471 ' OG ' HD22 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.672 ' HA ' HD12 ' B' ' 8' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 37' ' ' ILE . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' B' ' 17' ' ' SER . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' B' ' 2' ' ' ASN . 0.4 OUTLIER -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.968 HG23 ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 1.06 HD23 ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.49 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLU . . . . . 0.494 ' N ' HG23 ' B' ' 37' ' ' ILE . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.464 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' TYR . . . . . 0.616 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.471 HD22 ' OG ' ' A' ' 17' ' ' SER . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.53 ' HB3' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.21 0.529 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.83 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.6 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 11' ' ' SER . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 33' ' ' LEU . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 19' ' ' ARG . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 18' ' ' VAL . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 38' ' ' GLU . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.822 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.83 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.64 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.64 HG13 ' O ' ' B' ' 11' ' ' SER . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 1.065 HG11 HD13 ' B' ' 33' ' ' LEU . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.542 HG12 ' O ' ' B' ' 19' ' ' ARG . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.54 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.065 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 38' ' ' GLU . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.516 HD12 ' O ' ' B' ' 41' ' ' VAL . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.469 0.652 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.013 ' CZ3' HD21 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.965 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.015 HD21 ' CZ3' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 1.015 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.682 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.974 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.974 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.876 HG22 ' CE2' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.514 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.535 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.013 HD21 ' CZ3' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.876 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.784 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 1.3 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.25 0.548 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.816 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.804 HD11 ' HE3' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.649 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 HD11 HG11 ' A' ' 18' ' ' VAL . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' GLU . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.804 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.816 HD11 ' HE3' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.796 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.651 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 22' ' ' ILE . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.0 OUTLIER -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.476 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.484 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.562 HD11 HG11 ' B' ' 18' ' ' VAL . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.492 ' O ' HG22 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 38' ' ' GLU . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' B' ' 49' ' ' ALA . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' B' ' 33' ' ' LEU . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.755 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.529 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.56 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.045 HD21 ' CH2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 1.045 ' CH2' HD21 ' A' ' 33' ' ' LEU . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.76 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.533 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.559 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.559 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.479 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.619 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.258 0.552 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.63 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.009 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.009 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.638 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.677 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 7.4 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.766 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.718 ' HA ' HD12 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.006 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.006 HG22 ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.542 ' HB3' HD22 ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.675 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.675 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 7.4 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.765 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.633 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.633 HG22 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.225 0.536 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' B' ' 12' ' ' PRO . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.544 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.067 ' O ' HG22 ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.621 ' HA ' HD12 ' B' ' 8' ' ' ILE . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.711 ' OE2' HG11 ' B' ' 14' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 42' ' ' ARG . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' A' ' 12' ' ' PRO . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.572 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.062 ' O ' HG22 ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.062 HG22 ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.545 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.784 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 8' ' ' ILE . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.7 ' OE2' HG11 ' A' ' 14' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 42' ' ' ARG . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.426 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.628 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.406 ' OXT' ' HG2' ' B' ' 51' ' ' GLU . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.234 0.54 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.005 ' CZ3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.089 ' O ' HG22 ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.089 HG22 ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 33' ' ' LEU . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.998 HD13 ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' HD12 ' B' ' 8' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' GLU . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.998 ' CZ3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.093 ' O ' HG22 ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.43 ' HD3' HG23 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.093 HG22 ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' B' ' 33' ' ' LEU . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.761 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.761 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.005 HD13 ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.487 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 38' ' ' GLU . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.574 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.802 HG11 ' HB3' ' A' ' 33' ' ' LEU . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.776 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.776 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.548 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 41' ' ' VAL . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.88 ' O ' HG22 ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.88 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' B' ' 33' ' ' LEU . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.775 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.775 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.678 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA2' HD21 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.546 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.584 ' O ' HD12 ' B' ' 45' ' ' LEU . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.421 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.584 HD12 ' O ' ' B' ' 41' ' ' VAL . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.222 0.534 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' OE1' ' B' ' 38' ' ' GLU . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.862 ' O ' HG22 ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' N ' HG21 ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.952 HG11 ' OE2' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 33' ' ' LEU . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.698 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.809 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HZ ' HG12 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.933 ' OE2' HG11 ' B' ' 14' ' ' VAL . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.899 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.899 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.669 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' SD ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.423 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.761 HG12 ' OE1' ' A' ' 38' ' ' GLU . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.551 ' N ' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.933 HG11 ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' B' ' 33' ' ' LEU . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.697 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.543 ' CZ ' ' HB2' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.808 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.952 ' OE2' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.9 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.429 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.9 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.668 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.234 0.54 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.759 ' CH2' HD11 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.982 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.071 HG11 ' OE1' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.804 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 1.026 ' N ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.675 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.675 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.716 ' CD1' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 1.064 ' OE1' HG11 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.716 HG13 ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.719 ' HH ' ' HE2' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.468 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.761 ' CH2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.664 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.981 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.064 HG11 ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.806 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.806 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.022 HD23 ' N ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 1.022 ' N ' HD23 ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.672 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.672 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.713 ' CD1' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 1.071 ' OE1' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.713 HG13 ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.719 ' HE2' ' HH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.568 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.308 0.575 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.923 ' CZ2' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 14' ' ' VAL . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.16 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.16 HG22 ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.561 ' HB3' HD22 ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 33' ' ' LEU . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' A' ' 34' ' ' SER . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.731 ' CD1' HG11 ' A' ' 18' ' ' VAL . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' A' ' 32' ' ' ASP . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.612 HG13 HD13 ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 37' ' ' ILE . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' OG ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HG3' HG12 ' A' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.64 ' NE1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 37' ' ' ILE . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.82 ' HB ' HG11 ' B' ' 14' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.614 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.627 ' N ' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.638 ' OD1' HG13 ' B' ' 14' ' ' VAL . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.923 ' O ' HG23 ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.526 ' N ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.423 ' OG ' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.699 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.502 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.923 HD23 ' CZ2' ' A' ' 6' ' ' TRP . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.625 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.625 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.404 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' B' ' 46' ' ' PHE . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.515 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.515 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.244 0.545 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' B' ' 33' ' ' LEU . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 14' ' ' VAL . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.982 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.579 ' HB2' HG22 ' B' ' 8' ' ' ILE . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.686 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 37' ' ' ILE . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.688 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 45' ' ' LEU . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' A' ' 33' ' ' LEU . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 14' ' ' VAL . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.882 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.882 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.981 HG11 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.981 ' HB3' HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.826 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.4 ' N ' HG23 ' B' ' 37' ' ' ILE . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.686 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.289 0.566 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.748 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.728 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' A' ' 14' ' ' VAL . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.616 ' HB3' HD13 ' B' ' 45' ' ' LEU . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.659 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' B' ' 17' ' ' SER . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.753 ' CZ2' HD11 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' B' ' 14' ' ' VAL . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.775 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.618 ' HB3' HD22 ' A' ' 45' ' ' LEU . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.656 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.565 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.656 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.517 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.517 HG22 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 17' ' ' SER . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.556 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.408 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.408 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.152 0.501 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.725 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' B' ' 6' ' ' TRP . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.82 ' OD1' HG13 ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.82 HG13 ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.836 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 33' ' ' LEU . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 4.1 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 34' ' ' SER . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' B' ' 17' ' ' SER . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.724 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 6' ' ' TRP . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.629 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.819 ' OD1' HG13 ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.819 HG13 ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.823 ' HB3' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.85 HG11 HD22 ' B' ' 33' ' ' LEU . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 4.2 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.85 HD22 HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 34' ' ' SER . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.836 HD22 ' HB3' ' A' ' 17' ' ' SER . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.569 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.464 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.138 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.772 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG21 ' A' ' 14' ' ' VAL . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 14' ' ' VAL . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.773 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' B' ' 17' ' ' SER . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.666 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.507 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.745 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.578 ' HB ' HG21 ' B' ' 14' ' ' VAL . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.613 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.424 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.554 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 14' ' ' VAL . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.516 ' O ' HG22 ' B' ' 37' ' ' ILE . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.773 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.484 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.789 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.963 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.435 ' C ' ' OD1' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.453 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.574 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.958 HD23 ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 37' ' ' ILE . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.958 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.454 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.81 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.81 HG22 ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.57 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.513 ' C ' ' CD1' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.647 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.963 HD23 ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.683 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.579 ' O ' HG22 ' B' ' 41' ' ' VAL . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.683 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' SER . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.252 0.548 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.05 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 14' ' ' VAL . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.555 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.915 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CB ' ' CZ ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.886 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.886 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 14' ' ' VAL . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.56 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.558 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.05 HD23 ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.915 HD12 ' CD1' ' A' ' 37' ' ' ILE . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.637 HD12 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.662 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.555 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.216 0.532 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.403 ' CB ' ' OD1' ' B' ' 7' ' ' ASN . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.016 ' O ' HG22 ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.016 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.623 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.842 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.842 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.403 ' OD1' ' CB ' ' A' ' 7' ' ' ASN . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.014 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.014 HG22 ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.695 ' O ' HG23 ' B' ' 22' ' ' ILE . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.622 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.695 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.483 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.566 ' CG ' HD23 ' B' ' 33' ' ' LEU . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.853 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.626 ' O ' HG22 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 38' ' ' GLU . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.416 ' N ' HG23 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.569 ' OD1' ' ND2' ' B' ' 7' ' ' ASN . 3.1 m-20 -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 1.043 ' O ' HG22 ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.043 HG22 ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 19.9 mm100 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.59 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 37' ' ' ILE . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 41' ' ' VAL . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 7' ' ' ASN . 3.1 m-20 -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.478 HG13 HG13 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 1.035 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 1.035 HG22 ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.442 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . 0.578 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 20.0 mm100 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.591 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.513 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ILE . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.453 HD12 ' O ' ' B' ' 41' ' ' VAL . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 8.5 p30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.56 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.06 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.974 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.471 ' OG ' HD22 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.672 ' HA ' HD12 ' B' ' 8' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 37' ' ' ILE . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' B' ' 17' ' ' SER . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 8.5 p30 -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.968 HG23 ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 1.06 HD23 ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.49 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . 0.494 ' N ' HG23 ' B' ' 37' ' ' ILE . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.464 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' TYR . . . . . 0.616 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.471 HD22 ' OG ' ' A' ' 17' ' ' SER . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.53 ' HB3' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.262 0.553 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.92 119.06 11.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.4 p -57.43 149.13 21.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.211 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 70.9 t -99.54 149.32 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.04 111.89 23.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.869 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.83 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.64 137.72 32.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 110.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.24 112.29 15.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.011 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.822 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.6 pt -141.82 147.06 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.989 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.17 137.09 44.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.6 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.9 m -141.44 165.06 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.945 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.47 142.23 83.88 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.141 -0.974 . . . . 0.0 109.921 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -54.4 -13.9 6.04 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 110.915 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.535 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 11' ' ' SER . 1.3 m -74.12 -43.12 51.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.72 -0.612 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 10.0 t70 -61.06 -48.45 81.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.17 -42.49 81.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 110.023 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' HD13 ' B' ' 45' ' ' LEU . 93.9 p -64.53 -38.39 90.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 0.0 110.081 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 33' ' ' LEU . 70.8 t -61.34 -47.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.298 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.541 ' O ' HG12 ' A' ' 22' ' ' ILE . 5.5 ttt180 -68.0 -30.83 70.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.22 97.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.74 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -57.81 -50.27 73.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.749 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 19' ' ' ARG . 28.4 pt -65.62 -41.94 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.102 -0.999 . . . . 0.0 110.343 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.28 -38.31 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.941 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.15 -0.969 . . . . 0.0 109.396 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -98.51 -2.15 39.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.798 . . . . 0.0 110.345 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 162.34 -111.59 0.48 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.74 -10.78 0.81 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.56 67.11 0.51 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -83.63 166.78 17.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -1.14 . . . . 0.0 110.275 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -73.71 -70.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -54.2 -168.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -129.84 -161.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -1.17 . . . . 0.0 110.228 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 18' ' ' VAL . 1.3 tp -63.07 -35.51 80.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.32 -37.04 64.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.614 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -70.35 -36.82 74.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.023 . . . . 0.0 110.326 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.32 -48.02 77.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.301 -0.874 . . . . 0.0 110.557 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -74.72 -35.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.039 . . . . 0.0 110.43 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -57.26 -48.0 79.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.97 . . . . 0.0 110.611 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -69.1 -30.91 69.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.23 78.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 38' ' ' GLU . 32.0 m -67.14 -34.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.935 . . . . 0.0 110.512 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -62.75 -41.98 99.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.394 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.04 86.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -69.25 -48.21 62.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.648 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 41' ' ' VAL . 13.3 mt -58.05 -39.0 77.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.529 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -69.27 -45.57 69.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.275 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 1.5 tt0 -54.77 -51.07 66.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 11.8 mmt180 -68.77 -18.16 64.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 109.977 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -64.2 -49.16 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.232 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.38 -41.82 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.126 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.328 0.585 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -141.98 118.75 11.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.891 . . . . 0.0 110.13 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -57.11 149.35 19.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.9 t -99.67 149.09 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.081 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.74 111.97 23.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.822 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.84 137.43 33.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 110.091 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -126.21 112.34 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.025 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.83 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.6 pt -141.92 147.29 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.96 -1.088 . . . . 0.0 110.934 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.35 137.33 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.7 m -141.54 165.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.64 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.59 142.4 83.77 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.835 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -54.45 -13.96 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.854 1.449 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' B' ' 11' ' ' SER . 0.3 OUTLIER -72.56 -27.1 62.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.64 HG13 ' O ' ' B' ' 11' ' ' SER . 1.3 m -74.2 -43.21 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.726 -0.609 . . . . 0.0 110.488 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.554 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 10.1 t70 -60.92 -48.54 81.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -57.19 -42.39 81.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.032 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 94.8 p -64.5 -38.47 91.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.064 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 1.065 HG11 HD13 ' B' ' 33' ' ' LEU . 69.6 t -61.27 -47.35 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.542 ' O ' HG12 ' B' ' 22' ' ' ILE . 6.3 ttt180 -68.07 -30.69 69.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -43.25 96.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -57.78 -50.26 73.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 110.744 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.542 HG12 ' O ' ' B' ' 19' ' ' ARG . 28.5 pt -65.6 -41.91 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.11 -0.994 . . . . 0.0 110.443 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.54 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.35 -38.12 68.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.913 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.17 -26.55 60.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.514 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -98.7 -2.14 38.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.472 -0.767 . . . . 0.0 110.389 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 162.19 -111.56 0.48 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.48 -10.68 0.84 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.19 67.12 0.51 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' B' ' 29' ' ' ARG . 0.2 OUTLIER -84.04 166.8 17.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -1.158 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -73.7 -70.57 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . -53.98 -169.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -129.68 -161.38 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -1.19 . . . . 0.0 110.23 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.065 HD13 HG11 ' B' ' 18' ' ' VAL . 1.3 tp -62.75 -35.6 80.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 110.361 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 3.5 p -54.25 -37.01 64.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 110.63 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -70.44 -36.8 74.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.34 -47.96 77.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.585 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.552 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -74.71 -35.81 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.401 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.93 80.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 110.664 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -69.13 -30.85 69.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.3 -46.02 78.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.426 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.583 HG22 ' O ' ' B' ' 38' ' ' GLU . 32.2 m -67.31 -35.04 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -62.39 -42.11 99.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 -179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.98 87.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.118 -0.989 . . . . 0.0 110.763 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.506 ' O ' ' HG2' ' B' ' 48' ' ' ARG . 0.9 OUTLIER -69.37 -48.4 61.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.712 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.516 HD12 ' O ' ' B' ' 41' ' ' VAL . 13.2 mt -57.71 -39.12 76.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.602 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -69.3 -45.48 69.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.342 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 1.4 tt0 -54.97 -50.93 67.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 12.0 mmt180 -68.63 -18.21 64.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -64.54 -48.99 73.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.12 -41.89 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.882 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.996 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.05 176.17 5.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.58 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 69.3 p -75.29 145.2 42.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 60.7 t -97.5 151.09 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtm-85 -83.73 123.16 29.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.54 -0.725 . . . . 0.0 110.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.013 ' CZ3' HD21 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.18 114.45 16.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.16 -0.963 . . . . 0.0 111.042 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 7' ' ' ASN . 26.1 p-10 -104.49 117.99 35.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.87 . . . . 0.0 109.55 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -137.14 158.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.125 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.17 127.57 46.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.019 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.681 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 3.6 m -135.97 164.6 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 109.798 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.965 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -77.45 131.18 72.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.04 . . . . 0.0 110.462 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -45.76 -15.12 0.13 Allowed 'Trans proline' 0 C--N 1.301 -1.958 0 O-C-N 123.428 1.225 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' SER . 4.5 m-20 -74.24 -27.83 60.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -76.45 -33.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 110.725 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -64.65 -49.34 71.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.854 -1.154 . . . . 0.0 109.813 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' SD ' ' A' ' 20' ' ' MET . 3.9 mt-30 -58.67 -39.04 79.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 0.0 110.362 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.02 -37.49 75.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 36' ' ' PHE . 23.6 t -66.55 -45.62 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.688 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.562 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 9.0 mmt180 -66.65 -45.85 77.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 0.0 110.115 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -61.37 -40.01 92.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.862 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 12.6 t80 -57.59 -50.48 73.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 110.769 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 30.2 pt -62.52 -36.72 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.961 -1.087 . . . . 0.0 109.952 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.48 -32.37 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.95 60.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 26' ' ' GLY . 15.9 tt0 -94.14 18.58 10.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.499 -0.751 . . . . 0.0 109.955 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -33.29 111.02 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.43 -31.75 0.21 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.3 152.42 33.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 30' ' ' LYS . 11.0 mtp180 -71.94 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -1.164 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 4.8 mmpt? -57.3 -160.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.136 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.9 124.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -118.16 -86.57 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -1.195 . . . . 0.0 110.546 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.015 HD21 ' CZ3' ' B' ' 6' ' ' TRP . 0.5 OUTLIER -69.31 -50.6 45.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.45 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -37.73 65.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.966 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -70.3 -39.01 75.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.044 -1.035 . . . . 0.0 110.7 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.24 70.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.201 -0.937 . . . . 0.0 110.696 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.787 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -72.98 -37.55 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.03 -1.044 . . . . 0.0 110.521 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 mt-10 -57.12 -48.44 78.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.887 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.69 -31.49 68.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.75 -46.14 83.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.393 -0.817 . . . . 0.0 110.924 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.8 m -70.38 -34.64 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.723 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -58.52 -42.78 88.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.123 -0.986 . . . . 0.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.07 81.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 110.684 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.68 -49.14 56.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.609 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.67 -31.42 72.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.616 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -45.55 75.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.508 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -61.65 -42.58 99.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.778 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 1.4 mtt85 -72.42 -24.41 61.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.511 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 110.47 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -69.76 -29.34 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.15 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 30.5 tt0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.423 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.271 0.558 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -99.09 176.67 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.644 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 70.1 p -75.78 145.26 40.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.816 . . . . 0.0 109.667 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.2 t -97.6 151.02 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 47.3 mtm-85 -83.55 123.12 29.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.775 . . . . 0.0 110.384 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 1.015 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.11 114.46 16.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.105 -0.997 . . . . 0.0 111.081 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 7' ' ' ASN . 26.5 p-10 -104.44 117.9 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 109.591 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -137.13 158.48 36.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.086 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.739 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -100.26 127.54 46.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.001 . . . . 0.0 110.971 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.682 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 3.9 m -135.58 164.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 109.763 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.974 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -77.78 130.39 73.51 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.937 -1.102 . . . . 0.0 110.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -44.99 -15.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.302 -1.92 0 O-C-N 123.426 1.224 . . . . 0.0 110.984 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' B' ' 11' ' ' SER . 4.4 m-20 -74.12 -27.79 61.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.002 -1.061 . . . . 0.0 110.729 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.974 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.29 -33.45 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 110.727 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -64.66 -49.28 71.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.868 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.448 ' O ' ' SD ' ' B' ' 20' ' ' MET . 3.9 mt-30 -58.59 -39.06 79.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -37.67 75.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.876 HG22 ' CE2' ' B' ' 36' ' ' PHE . 24.1 t -66.42 -45.69 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.694 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.561 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 8.9 mmt180 -66.62 -45.94 77.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.096 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -61.25 -40.08 92.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.14 -0.975 . . . . 0.0 109.905 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.514 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 12.8 t80 -57.49 -50.43 73.07 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.465 -0.772 . . . . 0.0 110.905 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 30.2 pt -62.59 -36.73 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.045 . . . . 0.0 109.908 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.535 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -58.55 -32.18 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.59 -32.91 60.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.562 -0.711 . . . . 0.0 109.393 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 16.0 tt0 -94.21 18.39 11.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 109.887 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -33.18 111.06 0.06 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.48 -31.86 0.21 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.23 152.73 32.76 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 30' ' ' LYS . 11.0 mtp180 -72.09 -142.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -1.142 . . . . 0.0 110.259 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 4.8 mmpt? -57.38 -160.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 60.77 124.88 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.5 OUTLIER -118.07 -86.82 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.203 . . . . 0.0 110.527 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.013 HD21 ' CZ3' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -69.01 -50.71 46.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 110.529 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -37.77 65.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 111.015 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -70.22 -39.05 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.99 -1.069 . . . . 0.0 110.656 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.876 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -55.72 -50.11 71.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 0.0 110.723 -179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.784 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.4 OUTLIER -73.2 -37.45 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.975 -1.078 . . . . 0.0 110.417 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.9 mt-10 -57.19 -48.47 78.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -70.65 -31.66 68.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.065 -1.022 . . . . 0.0 109.97 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.02 84.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.522 -0.736 . . . . 0.0 111.021 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.784 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.9 m -70.45 -34.81 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.66 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' B' ' 41' ' ' VAL . 0.0 OUTLIER -58.25 -42.8 87.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.116 -0.99 . . . . 0.0 110.61 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.75 83.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.683 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -69.07 -49.01 61.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.964 . . . . 0.0 110.655 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -32.06 73.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.6 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -45.18 78.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -62.23 -42.36 99.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 110.795 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.518 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 1.3 mtt85 -72.34 -24.34 61.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.023 . . . . 0.0 110.616 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.32 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' B' ' 51' ' ' GLU . 0.4 OUTLIER -69.58 -28.57 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 50' ' ' VAL . 31.6 tt0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.159 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 1.3 p-10 -140.53 136.44 32.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.15 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -84.67 150.23 25.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.288 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 78.4 t -104.02 149.72 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.007 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -88.31 110.71 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.366 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.816 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -93.65 148.96 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 110.852 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.426 ' OD1' ' C ' ' A' ' 6' ' ' TRP . 10.3 m-20 -127.75 114.19 16.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.792 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.804 HD11 ' HE3' ' B' ' 6' ' ' TRP . 17.3 pt -141.08 147.19 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.401 -1.32 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -108.23 132.74 53.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.138 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 5.8 m -141.6 164.37 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 0.0 110.039 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.61 84.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.042 -1.036 . . . . 0.0 109.506 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.649 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.0 Cg_endo -62.98 -6.84 10.23 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.393 1.207 . . . . 0.0 110.44 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.34 -31.11 62.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 110.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -76.89 -30.83 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.518 -0.739 . . . . 0.0 110.726 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.55 -48.88 68.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.023 -1.048 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -58.65 -34.79 71.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.418 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -74.98 -38.11 61.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.6 t -64.42 -43.78 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.185 -0.947 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.0 -46.07 92.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.661 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -37.09 79.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.856 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -60.56 -42.5 96.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.751 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.81 -38.1 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.959 -1.088 . . . . 0.0 109.823 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 22' ' ' ILE . . . -56.85 -29.79 63.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.69 60.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -99.16 -2.79 35.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.066 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.565 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 29.22 51.76 0.13 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 175.37 8.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.04 -153.44 5.45 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -109.13 -7.48 15.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -1.15 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' CA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -57.29 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.208 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 35' ' ' ARG . . . -60.59 129.9 47.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.7 p30 -105.84 -138.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.294 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD11 HG11 ' A' ' 18' ' ' VAL . 3.9 tp -63.62 -45.05 92.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 110.385 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.3 p -58.32 -33.92 70.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NE ' ' OD2' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -70.59 -40.79 73.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 110.677 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -56.01 -47.75 77.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.146 -0.971 . . . . 0.0 110.542 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.528 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -73.18 -37.47 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.018 . . . . 0.0 110.425 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -57.72 -48.34 79.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.289 -0.882 . . . . 0.0 111.035 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' OD2' ' NE ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -67.75 -31.7 71.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.055 -179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -66.59 -46.1 77.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.445 -0.785 . . . . 0.0 110.483 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' GLU . 21.0 m -72.51 -35.62 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 110.469 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -66.48 -42.86 86.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.74 98.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 110.799 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.7 m-30 -66.66 -38.52 87.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 61.5 mt -71.3 -29.72 65.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.683 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.53 -45.15 55.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.5 -49.47 77.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.978 . . . . 0.0 110.475 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -19.95 62.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -70.26 -46.0 65.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.135 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.83 -42.8 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.241 179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.211 0.529 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' B' ' 2' ' ' ASN . 1.4 p-10 -140.78 136.49 32.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -84.66 150.42 25.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.346 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 79.3 t -104.1 149.67 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 109.974 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -88.2 110.76 20.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.178 -0.952 . . . . 0.0 109.317 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.804 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -93.66 148.82 21.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 111.005 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' B' ' 6' ' ' TRP . 10.4 m-20 -127.78 114.23 17.0 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.776 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.816 HD11 ' HE3' ' A' ' 6' ' ' TRP . 17.4 pt -141.11 147.38 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.582 -1.324 . . . . 0.0 110.941 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -108.36 132.89 53.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 6.0 m -141.61 164.32 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.796 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.6 OUTLIER -74.61 147.21 84.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.524 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.651 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.2 Cg_endo -62.55 -6.8 9.4 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.417 1.22 . . . . 0.0 110.555 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.35 -31.14 62.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.51 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -76.89 -30.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.807 . . . . 0.0 110.7 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -66.64 -49.0 67.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.11 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.52 -34.74 71.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 110.429 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -75.16 -38.09 61.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.928 . . . . 0.0 110.364 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 22' ' ' ILE . 16.4 t -64.43 -43.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.335 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.601 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.16 -46.08 92.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.71 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.25 -37.16 79.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.828 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -60.55 -42.67 97.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.601 HG12 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.62 -38.02 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.899 -1.126 . . . . 0.0 109.813 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' B' ' 22' ' ' ILE . . . -56.87 -29.86 63.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.302 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.52 -32.78 60.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.627 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.0 OUTLIER -99.09 -2.82 36.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.103 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 29.16 52.0 0.13 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.28 175.28 8.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.95 -153.47 5.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -109.21 -6.89 15.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -1.202 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.476 ' HE3' ' CA ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -57.92 -92.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.484 ' HA3' ' HG2' ' B' ' 35' ' ' ARG . . . -60.63 129.81 47.45 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.8 p30 -105.75 -138.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -1.112 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.562 HD11 HG11 ' B' ' 18' ' ' VAL . 4.0 tp -63.81 -44.99 91.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.342 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.492 ' O ' HG22 ' B' ' 37' ' ' ILE . 9.0 p -58.09 -34.58 70.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.527 ' NE ' ' OD2' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -70.15 -40.77 74.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 110.64 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -56.02 -47.48 77.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -73.66 -37.37 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.438 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.5 OUTLIER -57.71 -48.38 79.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.262 -0.899 . . . . 0.0 111.043 -179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.527 ' OD2' ' NE ' ' B' ' 35' ' ' ARG . 0.4 OUTLIER -67.64 -31.67 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 110.108 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.6 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.58 -46.23 76.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 38' ' ' GLU . 20.3 m -72.4 -35.57 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -66.59 -42.85 86.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 110.737 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.65 98.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.213 -0.929 . . . . 0.0 110.778 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 2.7 m-30 -66.64 -38.58 87.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.105 -0.997 . . . . 0.0 110.479 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' B' ' 49' ' ' ALA . 64.6 mt -71.34 -29.9 65.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.25 -45.12 57.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.57 -49.45 77.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.559 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -19.87 62.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.4 -45.99 64.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.988 . . . . 0.0 110.177 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.76 -42.39 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.943 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.283 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.233 0.539 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 34.1 t30 -160.01 144.06 14.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.0 p -71.43 142.99 50.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 61.3 t -104.58 148.48 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -91.5 114.86 27.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.949 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' B' ' 33' ' ' LEU . 1.4 m0 -92.69 149.36 21.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 110.771 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 7' ' ' ASN . 34.2 p-10 -129.51 113.84 15.36 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.755 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.3 OUTLIER -141.73 148.23 21.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.562 -178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -107.63 130.83 54.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' B' ' 6' ' ' TRP . 2.4 m -140.91 164.01 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.148 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 4.8 t -77.57 132.11 69.69 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.4 Cg_endo -46.17 -12.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.609 1.321 . . . . 0.0 111.131 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 t0 -72.99 -29.85 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.077 -1.014 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -76.94 -30.29 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' OD1' ' NE1' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -65.38 -48.87 71.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.411 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.58 -33.72 71.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.173 -0.955 . . . . 0.0 110.599 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -76.28 -37.97 56.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 110.432 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 14' ' ' VAL . 53.4 t -66.78 -41.57 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 110.636 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.529 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -66.91 -46.59 74.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.894 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.6 -36.69 81.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 6.3 t80 -62.44 -46.28 89.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.761 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.56 HG13 ' N ' ' A' ' 23' ' ' ALA . 45.4 pt -69.91 -39.22 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 110.626 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.34 -49.12 78.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.955 -1.091 . . . . 0.0 108.852 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -30.64 71.5 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.61 -0.681 . . . . 0.0 109.298 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' O ' ' C ' ' A' ' 26' ' ' GLY . 18.1 mm100 -93.99 -2.91 52.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.772 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 33.13 73.72 0.07 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.91 -166.59 37.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.69 154.31 46.91 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -80.78 -14.42 58.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.147 . . . . 0.0 110.231 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 2.8 mmmm -45.36 -66.82 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.55 169.11 13.54 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 33' ' ' LEU . 4.2 p30 -124.08 -110.41 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -1.137 . . . . 0.0 110.172 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.045 HD21 ' CH2' ' B' ' 6' ' ' TRP . 0.7 OUTLIER -62.79 -45.89 90.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.01 . . . . 0.0 110.177 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.94 -33.56 67.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 110.505 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' NH1' ' CG ' ' A' ' 35' ' ' ARG . 4.0 tpt180 -70.21 -38.98 75.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -46.57 80.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 110.416 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -38.97 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.995 . . . . 0.0 110.584 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.631 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -57.55 -47.81 81.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -62.51 -30.78 71.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.861 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.33 -46.31 73.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.497 -0.752 . . . . 0.0 110.75 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' GLU . 3.8 m -72.43 -34.2 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.95 . . . . 0.0 110.448 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -35.25 80.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . . . -67.79 -42.03 82.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 110.639 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.74 -42.9 69.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.845 . . . . 0.0 111.308 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 9.5 mt -71.4 -42.66 68.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.959 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -66.8 -40.62 88.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 110.513 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -54.63 -47.91 72.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -0.917 . . . . 0.0 110.121 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.624 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 6.3 tpt180 -80.09 -8.11 59.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.949 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.84 -48.36 16.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 110.672 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.0 p -71.26 -35.41 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.443 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.143 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.347 0.594 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 34.2 t30 -159.98 144.09 14.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 67.1 p -71.5 143.13 50.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 61.9 t -104.53 148.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.458 ' NH1' ' HG2' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -91.44 114.91 27.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 1.045 ' CH2' HD21 ' A' ' 33' ' ' LEU . 1.4 m0 -92.72 149.33 21.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 110.805 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' B' ' 7' ' ' ASN . 34.1 p-10 -129.61 113.78 15.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.76 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -141.7 148.18 21.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 117.74 -1.584 . . . . 0.0 111.574 -179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -107.55 130.76 54.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 6' ' ' TRP . 2.4 m -140.82 164.05 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.7 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 4.8 t -77.61 132.02 69.76 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 110.213 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.8 Cg_endo -46.1 -12.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 123.653 1.344 . . . . 0.0 111.142 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 11' ' ' SER . 50.2 t0 -73.2 -29.59 62.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.969 -1.082 . . . . 0.0 110.652 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.7 ' CG2' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -76.96 -30.38 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -48.86 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.496 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -59.64 -33.71 71.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.161 -0.962 . . . . 0.0 110.558 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.8 OUTLIER -76.31 -37.89 56.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.008 . . . . 0.0 110.387 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 14' ' ' VAL . 53.2 t -66.83 -41.62 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.61 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.533 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -66.86 -46.61 74.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmt -61.57 -36.83 81.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.471 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 6.0 t80 -62.42 -46.16 89.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 110.747 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.559 HG13 ' N ' ' B' ' 23' ' ' ALA . 45.4 pt -70.04 -39.14 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.97 -1.081 . . . . 0.0 110.606 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.559 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -60.34 -49.13 78.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.061 . . . . 0.0 108.809 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.52 71.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.74 . . . . 0.0 109.319 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' B' ' 26' ' ' GLY . 18.1 mm100 -94.06 -2.94 52.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.471 -0.768 . . . . 0.0 110.37 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 33.19 73.66 0.07 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.93 -166.62 37.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.58 154.34 47.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -80.81 -14.42 58.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -1.17 . . . . 0.0 110.276 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.466 ' N ' ' HG2' ' B' ' 29' ' ' ARG . 2.8 mmmm -45.38 -66.88 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.897 . . . . 0.0 110.059 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.42 169.16 13.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 33' ' ' LEU . 4.1 p30 -124.05 -110.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -1.157 . . . . 0.0 110.249 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -62.92 -45.78 90.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 110.199 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.479 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.04 -33.5 67.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.456 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH1' ' CG ' ' B' ' 35' ' ' ARG . 4.1 tpt180 -70.12 -39.21 75.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.489 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -46.72 79.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.127 -0.983 . . . . 0.0 110.413 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.619 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -38.89 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.956 . . . . 0.0 110.54 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.55 -47.32 82.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 110.76 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -63.09 -30.83 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.46 73.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.633 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.619 HG22 ' O ' ' B' ' 38' ' ' GLU . 3.9 m -72.29 -34.36 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -35.26 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.532 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 47' ' ' GLU . . . -67.75 -41.96 82.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 110.606 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -70.75 -42.88 69.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.249 -0.907 . . . . 0.0 111.311 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 9.6 mt -71.42 -42.96 67.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.066 -1.022 . . . . 0.0 110.909 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -66.47 -40.53 89.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.643 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 43' ' ' ALA . 0.1 OUTLIER -54.81 -47.85 73.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 6.4 tpt180 -80.08 -8.03 59.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.82 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.77 15.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.98 . . . . 0.0 110.646 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.9 p -70.86 -35.41 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 2.2 tt0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.196 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.75 152.12 51.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.183 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.0 p -94.51 142.54 27.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 110.224 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 39.8 t -99.29 149.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -102.74 133.58 47.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.34 113.89 16.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.381 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -104.77 117.66 34.63 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.353 -0.842 . . . . 0.0 108.823 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.2 OUTLIER -137.46 158.82 35.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.55 -178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.7 126.72 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.848 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.63 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 15.7 m -139.78 164.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.384 -0.823 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.009 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -77.2 128.44 80.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.012 -1.055 . . . . 0.0 109.906 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -48.41 -7.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.643 1.339 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.09 -26.92 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.082 . . . . 0.0 110.361 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.009 HG22 ' O ' ' A' ' 11' ' ' SER . 0.3 OUTLIER -75.37 -31.05 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 110.831 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -67.1 -48.85 66.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.866 -1.146 . . . . 0.0 109.971 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -58.04 -40.05 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 0.0 110.329 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' B' ' 45' ' ' LEU . 1.9 m -70.2 -37.25 75.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.1 t -60.2 -41.8 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.475 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.638 ' O ' HG12 ' A' ' 22' ' ' ILE . 3.6 tmt_? -64.15 -45.53 88.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.086 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mmm -61.48 -42.92 99.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.032 -1.043 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -59.56 -50.16 74.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.8 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.677 HG13 ' N ' ' A' ' 23' ' ' ALA . 19.4 pt -59.9 -38.25 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.997 -1.065 . . . . 0.0 109.892 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -58.64 -32.52 69.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.135 -0.978 . . . . 0.0 109.463 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.78 60.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.532 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 7.4 tt0 -92.56 -2.31 56.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.2 108.91 2.72 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.52 23.41 0.23 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.93 -43.98 0.19 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.57 154.33 32.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -1.125 . . . . 0.0 110.249 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 11.1 mtmt -102.05 -109.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.38 175.87 26.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 34' ' ' SER . 31.6 p-10 -123.06 -161.8 0.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -1.121 . . . . 0.0 110.072 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.766 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -73.38 -36.86 66.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.111 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.718 ' HA ' HD12 ' B' ' 8' ' ' ILE . 0.5 OUTLIER -53.75 -41.95 67.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.896 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -39.29 77.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.316 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -56.43 -46.87 80.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 110.47 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.24 -38.29 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.315 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -56.75 -48.0 78.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.716 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -31.25 68.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.12 84.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.428 -0.795 . . . . 0.0 110.978 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' GLU . 14.6 m -67.05 -34.47 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.616 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -59.42 -43.66 93.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.0 110.405 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.26 -41.24 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.721 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.38 -48.94 53.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.952 . . . . 0.0 110.704 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' B' ' 17' ' ' SER . 16.8 mt -57.04 -38.15 72.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 110.863 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.16 -45.51 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 110.21 -179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 8.9 tt0 -56.21 -41.4 75.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.228 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -75.24 -23.74 57.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.344 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.15 66.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 110.354 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.3 -52.37 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.265 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.25 0.548 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -134.83 152.99 52.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.8 p -95.31 142.63 27.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.303 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 42.0 t -99.45 149.11 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.9 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -102.91 133.56 47.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -127.25 113.96 17.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.856 -1.152 . . . . 0.0 111.354 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -104.86 117.41 33.96 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 108.811 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -137.25 158.86 35.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.668 -178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.76 126.85 42.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.842 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 15.4 m -139.83 164.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.006 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.81 128.08 82.49 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -48.24 -7.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.624 1.329 . . . . 0.0 111.32 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.3 -26.81 61.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 110.322 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.006 HG22 ' O ' ' B' ' 11' ' ' SER . 0.3 OUTLIER -75.38 -30.96 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.422 -0.799 . . . . 0.0 110.867 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -67.19 -48.8 66.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -58.19 -40.09 80.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.542 ' HB3' HD22 ' A' ' 45' ' ' LEU . 3.1 m -70.06 -37.45 75.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.962 . . . . 0.0 110.145 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.4 t -60.16 -41.68 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 22' ' ' ILE . 3.6 tmt_? -64.2 -45.42 88.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.071 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 1.4 mmm -61.56 -42.8 99.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.672 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.57 -50.16 74.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.764 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.675 HG13 ' N ' ' B' ' 23' ' ' ALA . 19.2 pt -60.0 -37.9 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.964 -1.085 . . . . 0.0 109.919 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.675 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -59.02 -32.49 69.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 109.469 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -32.92 60.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.426 -0.796 . . . . 0.0 109.473 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 7.4 tt0 -92.37 -2.38 56.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.439 -0.788 . . . . 0.0 109.946 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.01 109.06 2.74 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.65 23.58 0.22 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 170.79 -44.69 0.19 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -118.03 154.05 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -1.105 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 30' ' ' LYS . 10.9 mtmt -101.77 -109.38 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.069 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.42 176.56 26.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 34' ' ' SER . 29.0 p-10 -123.55 -161.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -1.157 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.765 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.4 OUTLIER -73.43 -36.95 66.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.875 . . . . 0.0 110.116 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -53.74 -41.95 67.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.923 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -39.17 77.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.336 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.517 ' CE2' HG22 ' B' ' 18' ' ' VAL . 0.4 OUTLIER -56.42 -46.99 79.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.473 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.633 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.37 -38.06 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.633 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -56.87 -47.91 79.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 110.618 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -31.38 68.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.069 -1.02 . . . . 0.0 109.852 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.29 -46.15 84.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 110.939 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.633 HG22 ' O ' ' B' ' 38' ' ' GLU . 15.4 m -66.78 -34.44 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 0.0 110.661 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -59.46 -43.45 93.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.447 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.42 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -59.53 -41.33 89.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 110.652 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.33 -48.99 53.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.89 . . . . 0.0 110.654 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 17' ' ' SER . 16.1 mt -56.92 -38.02 72.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.832 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -69.44 -45.53 68.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.075 -1.016 . . . . 0.0 110.278 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 8.3 tt0 -56.47 -39.45 73.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -77.09 -24.08 51.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.388 -0.82 . . . . 0.0 110.304 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.67 69.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.962 . . . . 0.0 110.367 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.58 -52.67 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.208 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.131 0.491 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -160.24 132.91 6.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -52.21 140.87 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.053 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' B' ' 12' ' ' PRO . 18.2 t -102.5 148.99 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.544 ' HD3' ' HB2' ' B' ' 7' ' ' ASN . 2.1 tmm_? -107.09 134.35 50.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.796 . . . . 0.0 109.104 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.1 OUTLIER -123.22 112.94 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.803 -1.186 . . . . 0.0 111.283 -179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 1.0 OUTLIER -109.33 124.97 51.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -139.19 166.74 21.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.594 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.05 122.05 39.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 110.82 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 21.8 m -141.77 164.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.727 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.067 ' O ' HG22 ' A' ' 14' ' ' VAL . 12.5 t -76.83 133.24 70.11 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' B' ' 4' ' ' VAL . 47.4 Cg_endo -51.42 -4.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.71 1.374 . . . . 0.0 111.026 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.94 -26.23 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.966 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 11' ' ' SER . 1.5 m -75.66 -35.67 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.735 . . . . 0.0 110.741 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.43 -49.01 68.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.864 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -59.95 -40.54 89.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.166 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -40.94 89.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' CG1' HD12 ' A' ' 33' ' ' LEU . 5.2 t -61.74 -40.35 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 110.294 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -67.68 -44.22 78.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.898 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 34.3 mmt -61.59 -40.7 95.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.37 -50.62 73.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 111.4 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -56.2 -36.09 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.885 -1.135 . . . . 0.0 110.1 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -57.01 -31.92 65.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 109.36 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.6 60.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' O ' ' C ' ' A' ' 26' ' ' GLY . 46.5 tp60 -94.67 -2.83 50.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 31.04 -134.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.42 -47.33 1.75 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 77.01 0.42 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -97.75 -97.6 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -1.119 . . . . 0.0 110.278 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -130.09 19.91 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 44.99 52.43 7.97 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD2' ' HB3' ' A' ' 34' ' ' SER . 12.1 t70 -126.15 122.75 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -73.08 -24.83 60.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.621 ' HA ' HD12 ' B' ' 8' ' ' ILE . 43.1 t -55.1 -33.71 63.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.473 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -70.29 -40.81 74.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.978 -1.076 . . . . 0.0 110.393 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -56.27 -49.51 74.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.422 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -69.65 -38.44 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.097 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.711 ' OE2' HG11 ' B' ' 14' ' ' VAL . 1.4 tp10 -57.47 -48.15 79.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.72 -32.07 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 0.0 109.993 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.27 83.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 110.744 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 42' ' ' ARG . 32.8 m -71.36 -34.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.45 -43.0 97.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -59.05 -37.05 76.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 110.292 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 110.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.76 -34.06 76.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -0.898 . . . . 0.0 110.962 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -65.75 -45.98 80.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.0 110.163 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 33.9 tp10 -55.1 -50.9 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 19.9 mmt180 -66.74 -16.27 64.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.912 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -63.79 -46.71 83.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.808 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.7 -37.94 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 110.037 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.159 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 mtm . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.092 0.473 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -160.27 132.22 6.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 76.7 p -51.68 141.71 16.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 110.052 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' A' ' 12' ' ' PRO . 17.0 t -102.94 149.07 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 2.1 tmm_? -106.92 133.97 50.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.052 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.572 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -122.93 112.87 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -109.23 124.81 51.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.4 -0.812 . . . . 0.0 109.272 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.621 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.16 166.81 21.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.501 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.23 121.85 39.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.841 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.558 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 22.3 m -141.41 164.28 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.429 -0.794 . . . . 0.0 109.748 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.062 ' O ' HG22 ' B' ' 14' ' ' VAL . 13.0 t -76.54 133.28 70.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.015 -1.053 . . . . 0.0 109.895 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.5 Cg_endo -51.42 -4.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.738 1.388 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -72.87 -26.21 61.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.072 -1.017 . . . . 0.0 110.012 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.062 HG22 ' O ' ' B' ' 11' ' ' SER . 1.4 m -75.71 -36.14 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.5 -0.75 . . . . 0.0 110.661 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.92 -49.02 69.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 109.862 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -60.14 -40.33 89.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.252 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -41.02 89.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.545 ' CG1' HD12 ' B' ' 33' ' ' LEU . 5.3 t -61.81 -40.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.247 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.876 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -67.63 -44.18 78.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.85 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 16' ' ' GLN . 34.2 mmt -61.5 -40.83 96.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.23 -50.51 73.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.322 -0.861 . . . . 0.0 111.389 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.876 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -56.43 -36.09 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.948 -1.095 . . . . 0.0 110.018 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.89 -32.03 65.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.46 60.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -0.766 . . . . 0.0 109.714 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' B' ' 26' ' ' GLY . 46.6 tp60 -94.71 -2.9 50.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 110.159 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.543 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 31.0 -135.0 0.09 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.34 -47.08 1.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.78 77.1 0.41 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -97.69 -97.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.15 . . . . 0.0 110.259 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' B' ' 31' ' ' GLY . 0.4 OUTLIER -130.1 20.28 5.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 110.245 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 44.49 52.68 7.31 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' B' ' 34' ' ' SER . 11.6 t70 -126.47 122.83 36.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -1.123 . . . . 0.0 110.27 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.784 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.5 OUTLIER -73.1 -24.81 60.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.381 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 8' ' ' ILE . 44.3 t -55.22 -33.5 63.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 -70.52 -40.87 73.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.3 OUTLIER -56.28 -49.69 73.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.434 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.589 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.33 -38.62 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.7 ' OE2' HG11 ' A' ' 14' ' ' VAL . 1.6 tp10 -57.4 -48.07 80.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.85 -32.18 69.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.964 -1.085 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.357 -0.84 . . . . 0.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 42' ' ' ARG . 32.9 m -71.26 -34.54 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 109.97 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.426 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.32 -43.27 96.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.929 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -58.83 -36.91 75.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.406 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -70.12 -42.93 72.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.576 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.9 -34.26 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 111.014 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.628 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 0.0 OUTLIER -65.55 -45.98 81.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.965 -1.084 . . . . 0.0 110.122 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 34.4 tp10 -55.0 -51.02 67.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 19.9 mmt180 -66.81 -16.28 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 110.006 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -63.68 -46.82 83.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.868 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.36 -38.6 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.406 ' OXT' ' HG2' ' B' ' 51' ' ' GLU . 23.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 147.99 48.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.882 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.2 p -95.24 134.16 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.7 t -100.61 148.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -101.43 132.39 47.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.005 ' CZ3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -130.5 113.83 14.76 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.466 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.91 119.77 40.03 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.379 -0.826 . . . . 0.0 108.949 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.07 163.23 34.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.483 -178.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.03 123.82 40.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.864 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.572 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 27.2 m -139.79 164.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.089 ' O ' HG22 ' A' ' 14' ' ' VAL . 7.1 t -78.43 138.49 59.37 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.988 . . . . 0.0 109.862 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' B' ' 4' ' ' VAL . 48.2 Cg_endo -49.77 -5.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.689 1.363 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.1 t0 -73.06 -26.16 61.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.089 HG22 ' O ' ' A' ' 11' ' ' SER . 2.1 m -74.01 -43.17 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.489 -0.757 . . . . 0.0 110.95 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -48.76 67.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.886 -1.134 . . . . 0.0 109.82 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -58.47 -42.3 87.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.111 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -65.34 -40.04 93.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 33' ' ' LEU . 25.3 t -60.92 -42.8 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 22' ' ' ILE . 4.6 mtp85 -62.87 -45.02 94.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.936 . . . . 0.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.7 98.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.912 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.45 -51.14 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 111.017 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -60.22 -37.87 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.77 -27.71 52.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.334 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.89 -29.02 58.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.454 -0.778 . . . . 0.0 109.211 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.71 -2.23 33.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.23 -99.99 0.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.24 177.19 40.3 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.39 160.82 33.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -115.54 -56.79 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.87 -100.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 110.315 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.13 103.71 0.7 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.6 -85.23 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.137 . . . . 0.0 110.219 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.998 HD13 ' CZ3' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -62.99 -47.69 82.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.613 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.578 ' HA ' HD12 ' B' ' 8' ' ' ILE . 2.2 t -54.3 -39.7 67.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.069 -1.019 . . . . 0.0 110.355 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -38.03 74.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.892 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -45.07 86.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 110.613 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -73.06 -37.59 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.046 -1.034 . . . . 0.0 110.539 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.19 -48.17 79.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.749 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.93 -31.24 70.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 110.033 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.32 73.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -0.787 . . . . 0.0 110.648 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' GLU . 25.0 m -72.26 -35.41 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.429 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' A' ' 41' ' ' VAL . 14.1 tpt180 -64.8 -38.36 90.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -64.48 -42.72 95.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.8 -43.13 72.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.011 . . . . 0.0 110.384 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -63.36 -33.18 74.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.55 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -69.95 -39.28 76.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 0.0 110.198 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HG3' ' CD2' ' A' ' 46' ' ' PHE . 52.6 mt-10 -67.29 -37.53 83.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.344 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -24.59 53.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.49 58.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.02 -34.35 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.35 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 34.3 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.6 147.61 48.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 78.9 p -94.95 134.62 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.9 t -100.92 148.55 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.917 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -101.29 132.36 46.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.998 ' CZ3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.59 113.89 14.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.875 -1.141 . . . . 0.0 111.501 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -106.1 119.55 39.5 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.859 . . . . 0.0 108.858 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -135.81 163.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.584 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.03 123.78 40.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.871 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 27.2 m -139.76 164.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.093 ' O ' HG22 ' B' ' 14' ' ' VAL . 7.6 t -78.78 138.43 57.91 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 109.734 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.43 ' HD3' HG23 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -49.6 -6.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.747 1.393 . . . . 0.0 111.06 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 11' ' ' SER . 3.1 t0 -72.99 -26.22 61.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 110.085 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.093 HG22 ' O ' ' B' ' 11' ' ' SER . 2.1 m -73.76 -43.23 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.438 -0.789 . . . . 0.0 110.938 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.08 -48.89 66.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.793 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -58.48 -42.5 87.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -65.14 -40.16 94.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' B' ' 33' ' ' LEU . 25.3 t -60.97 -42.71 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.441 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.761 ' O ' HG13 ' B' ' 22' ' ' ILE . 4.5 mtp85 -62.8 -45.01 94.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -42.76 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.955 . . . . 0.0 110.027 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -59.31 -50.85 72.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 111.077 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.761 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -60.55 -37.78 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.962 -1.086 . . . . 0.0 109.888 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.79 -27.81 52.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.256 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.96 58.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.234 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.82 -2.24 32.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 110.152 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.22 -99.75 0.4 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.9 177.07 40.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.25 160.94 33.11 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -115.25 -56.69 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.273 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -83.14 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.272 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.77 103.61 0.66 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -125.78 -85.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 110.251 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.005 HD13 ' CZ3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER -62.72 -47.76 82.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.016 . . . . 0.0 110.618 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 8' ' ' ILE . 2.1 t -54.35 -39.72 67.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.33 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -38.11 74.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.059 -1.026 . . . . 0.0 109.933 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -44.97 86.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.707 HD12 HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -73.1 -37.72 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.058 -1.026 . . . . 0.0 110.61 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.487 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.14 -48.03 79.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.104 -0.997 . . . . 0.0 110.837 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.1 -31.25 70.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.97 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 -46.29 73.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.76 . . . . 0.0 110.692 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 38' ' ' GLU . 24.9 m -72.31 -35.4 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 110.391 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.456 ' N ' HG23 ' B' ' 41' ' ' VAL . 13.8 tpt180 -64.58 -38.34 90.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -64.6 -42.24 95.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.22 -43.1 71.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 37.0 mt -63.49 -33.02 74.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 0.0 110.444 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -70.08 -39.23 75.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.574 ' HG3' ' CD2' ' B' ' 46' ' ' PHE . 52.4 mt-10 -67.45 -37.26 82.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 110.195 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -24.78 53.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.9 58.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.52 -35.39 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 47' ' ' GLU . 36.0 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.151 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.336 0.588 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.76 148.92 33.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.174 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 76.6 p -79.72 137.49 37.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 110.23 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 56.6 t -101.36 149.06 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.287 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -105.67 135.38 47.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.32 179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.3 OUTLIER -123.51 113.46 18.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.334 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' ASN . 12.3 p-10 -108.17 117.83 35.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.273 -0.892 . . . . 0.0 109.336 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 158.45 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.375 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.39 128.37 43.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.908 . . . . 0.0 110.669 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 24.7 m -142.08 164.3 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.049 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 14' ' ' VAL . 22.7 t -74.56 147.45 84.72 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.678 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.0 Cg_endo -64.07 -4.4 7.55 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.374 1.197 . . . . 0.0 110.582 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.16 -28.68 61.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.572 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.6 -36.67 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.832 . . . . 0.0 110.787 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.15 -49.03 66.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 109.708 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.71 -44.61 90.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.843 . . . . 0.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.16 -40.54 96.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.802 HG11 ' HB3' ' A' ' 33' ' ' LEU . 17.7 t -61.38 -42.72 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.395 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.776 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -62.84 -44.71 95.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.906 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mtt -63.03 -42.42 99.78 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -59.08 -51.45 70.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.393 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.776 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.4 pp -57.13 -36.87 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.889 -1.132 . . . . 0.0 109.979 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.62 -32.56 65.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 109.429 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.07 59.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.564 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 32.2 tt0 -94.44 -2.09 52.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 110.043 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.86 71.61 0.51 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 -109.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 -112.66 1.12 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -88.51 -175.28 4.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -75.44 162.34 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.055 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 33' ' ' LEU . . . 82.61 29.79 34.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 m-20 -97.3 20.68 11.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.265 -1.138 . . . . 0.0 110.341 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -74.08 -43.34 58.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.194 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.548 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -54.3 -44.18 71.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 0.0 111.182 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 32' ' ' ASP . 1.9 ptm180 -70.4 -36.6 74.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.846 -1.159 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -45.62 80.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.029 -1.045 . . . . 0.0 110.162 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.09 -36.54 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -57.23 -48.03 79.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 0.0 110.645 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.91 -31.09 69.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.54 79.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -0.776 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.5 m -68.88 -35.14 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.477 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -64.46 -42.78 95.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 110.307 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.26 -42.72 92.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 110.519 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.94 -45.39 82.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 41' ' ' VAL . 14.8 mt -62.65 -26.05 68.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.945 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.08 -41.1 77.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.251 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.41 -34.26 76.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.6 -19.96 34.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.18 97.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.932 . . . . 0.0 109.988 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 62.4 t -79.21 -29.23 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 63.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.09 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.263 0.554 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.03 148.69 32.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -79.56 138.46 37.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.2 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 56.5 t -101.58 148.96 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 110.1 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 0.2 OUTLIER -105.4 135.17 47.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.239 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.825 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -123.35 113.38 18.77 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.387 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 7' ' ' ASN . 12.6 p-10 -108.07 117.68 34.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.354 -0.841 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 158.46 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.45 127.84 42.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.779 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.551 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 25.7 m -141.54 164.17 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.762 . . . . 0.0 109.938 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.88 ' O ' HG22 ' B' ' 14' ' ' VAL . 23.3 t -74.59 147.59 84.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.112 -0.992 . . . . 0.0 109.605 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.1 Cg_endo -63.9 -4.62 7.66 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.483 1.254 . . . . 0.0 110.535 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -73.96 -28.86 61.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.88 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.59 -36.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.787 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.11 -49.08 66.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.63 -44.55 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 110.09 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -40.46 96.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.161 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' B' ' 33' ' ' LEU . 17.9 t -61.46 -42.85 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.364 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.775 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -62.74 -44.82 95.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.941 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.88 -42.35 99.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -59.28 -51.21 70.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.349 -0.845 . . . . 0.0 111.386 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.775 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.4 pp -57.4 -36.85 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.864 -1.148 . . . . 0.0 110.008 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.678 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.61 -32.6 65.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -32.08 59.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.534 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 32.5 tt0 -94.39 -2.12 52.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 46.92 71.32 0.55 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.8 -109.51 0.06 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.61 -113.0 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -88.07 -175.25 5.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.264 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -75.5 162.17 28.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.027 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA2' HD21 ' B' ' 33' ' ' LEU . . . 82.92 29.87 33.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 1.2 m-20 -97.43 20.54 11.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -1.133 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.825 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -74.01 -43.27 58.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.546 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -54.41 -44.12 72.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 111.233 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' B' ' 32' ' ' ASP . 1.8 ptm180 -70.5 -36.52 73.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.836 -1.165 . . . . 0.0 110.564 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -45.67 80.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 110.189 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.618 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.07 -36.35 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 0.0 110.334 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -57.38 -48.03 80.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.02 -31.05 69.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -45.36 80.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.453 -0.779 . . . . 0.0 110.528 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.584 ' O ' HD12 ' B' ' 45' ' ' LEU . 35.4 m -69.03 -35.06 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 110.567 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.421 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -64.51 -42.73 95.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.11 92.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 0.0 110.584 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.53 -45.1 84.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.496 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.584 HD12 ' O ' ' B' ' 41' ' ' VAL . 14.0 mt -62.92 -25.83 68.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -69.51 -40.98 76.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.414 -0.804 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.67 -34.03 76.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.79 -19.91 34.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.293 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.26 96.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' B' ' 51' ' ' GLU . 54.0 t -79.15 -28.89 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 50' ' ' VAL . 65.9 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.211 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.202 0.525 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -135.14 8.44 3.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 62.5 p -56.43 134.58 53.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 4.7 t -101.68 148.66 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 133.57 43.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 109.674 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' B' ' 7' ' ' ASN . 0.0 OUTLIER -134.23 114.1 12.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.883 -1.136 . . . . 0.0 111.406 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -105.31 121.3 43.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.322 -0.861 . . . . 0.0 108.84 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' HB3' ' B' ' 34' ' ' SER . 0.0 OUTLIER -136.71 162.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.589 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 122.23 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' OE1' ' B' ' 38' ' ' GLU . 11.4 m -140.59 164.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.348 -0.845 . . . . 0.0 109.962 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.862 ' O ' HG22 ' A' ' 14' ' ' VAL . 26.7 t -77.89 138.42 61.65 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.168 -0.957 . . . . 0.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' N ' HG21 ' B' ' 4' ' ' VAL . 47.7 Cg_endo -50.48 -5.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.649 1.342 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -72.95 -26.17 61.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.622 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.952 HG11 ' OE2' ' B' ' 38' ' ' GLU . 0.0 OUTLIER -73.2 -40.06 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.659 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.09 -48.79 67.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.88 -1.137 . . . . 0.0 110.023 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -58.39 -42.79 87.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 p -67.16 -38.71 85.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.165 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 33' ' ' LEU . 2.7 t -59.71 -41.56 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.283 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.7 ' O ' HG13 ' A' ' 22' ' ' ILE . 31.2 mmm-85 -62.28 -45.03 95.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.991 . . . . 0.0 109.934 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.65 -43.15 99.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -59.06 -51.0 71.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 111.099 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 19' ' ' ARG . 2.2 pp -61.66 -38.71 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.917 -1.115 . . . . 0.0 110.038 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.698 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.43 -31.74 64.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 109.286 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.18 59.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.734 . . . . 0.0 109.492 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.4 -2.18 46.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . 143.7 -144.5 13.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.83 66.12 0.51 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.14 -47.64 1.22 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -100.34 -123.91 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -1.184 . . . . 0.0 110.189 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -72.03 -170.41 0.59 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.287 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.59 126.08 1.48 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.54 117.29 29.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -1.195 . . . . 0.0 109.993 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.809 ' H ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -67.84 -26.72 66.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.889 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -56.27 -33.87 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.336 -0.852 . . . . 0.0 110.629 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -40.91 72.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.965 -1.084 . . . . 0.0 110.455 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HZ ' HG12 ' B' ' 41' ' ' VAL . 0.7 OUTLIER -56.57 -44.54 81.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.493 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -75.03 -38.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.544 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.933 ' OE2' HG11 ' B' ' 14' ' ' VAL . 0.4 OUTLIER -57.02 -48.26 78.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.968 . . . . 0.0 110.779 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.44 -31.49 72.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.697 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 -46.46 75.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 110.677 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.899 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . 34.3 m -72.25 -35.54 52.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.19 -0.943 . . . . 0.0 111.026 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -68.32 -43.41 77.64 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.406 -0.808 . . . . 0.0 110.551 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.69 74.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 111.62 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.899 ' CE2' ' HA ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.3 67.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.832 -1.168 . . . . 0.0 111.042 -178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.669 ' HG ' ' CE1' ' A' ' 44' ' ' TYR . 1.3 mt -56.85 -28.65 61.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.771 -1.206 . . . . 0.0 109.788 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -74.04 -39.15 63.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.428 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.83 -49.72 70.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.982 . . . . 0.0 110.315 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -19.61 59.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.66 89.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.243 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.16 -28.51 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.076 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.342 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' SD ' ' B' ' 1' ' ' MET . 3.6 tmm? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -135.14 8.57 3.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.187 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.423 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 64.7 p -56.51 134.68 54.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 4.8 t -101.82 148.66 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 109.817 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.54 43.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 109.653 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -134.21 114.08 12.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 111.413 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -105.41 121.16 43.34 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 108.79 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.54 163.11 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.621 -178.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.766 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.77 122.19 39.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.819 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.761 HG12 ' OE1' ' A' ' 38' ' ' GLU . 11.4 m -140.52 164.26 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.061 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' B' ' 14' ' ' VAL . 27.9 t -77.81 138.47 61.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 109.951 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.551 ' N ' HG21 ' A' ' 4' ' ' VAL . 48.0 Cg_endo -50.5 -5.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.636 1.335 . . . . 0.0 111.053 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 11' ' ' SER . 0.1 OUTLIER -72.95 -26.18 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.63 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.933 HG11 ' OE2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -73.19 -39.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.923 . . . . 0.0 110.716 -179.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.15 -48.75 67.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.031 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -58.37 -42.84 87.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.35 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.3 p -67.19 -38.62 85.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.194 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.671 ' CG1' HD12 ' B' ' 33' ' ' LEU . 2.6 t -59.72 -41.59 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.223 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.697 ' O ' HG13 ' B' ' 22' ' ' ILE . 30.7 mmm-85 -62.35 -44.81 95.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 2.9 mmt -62.83 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 109.909 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.96 -51.22 70.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 111.108 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 19' ' ' ARG . 2.2 pp -61.4 -38.77 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.682 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.34 -31.82 64.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 109.31 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.85 -31.17 59.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.54 -0.725 . . . . 0.0 109.486 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -96.42 -2.3 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 110.24 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' B' ' 23' ' ' ALA . . . 143.73 -144.42 13.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.77 66.1 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.04 -47.68 1.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.543 ' CZ ' ' HB2' ' B' ' 29' ' ' ARG . 0.7 OUTLIER -100.33 -123.71 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.158 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -72.06 -169.98 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.226 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.94 125.93 1.45 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.52 116.98 28.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 110.014 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.808 HD22 ' H ' ' B' ' 33' ' ' LEU . 0.2 OUTLIER -67.62 -26.81 66.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 37' ' ' ILE . 1.0 OUTLIER -56.21 -33.91 65.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.587 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.79 -40.79 72.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.983 -1.073 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -56.53 -44.56 80.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.907 . . . . 0.0 110.498 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -75.06 -38.57 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.478 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.952 ' OE2' HG11 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -57.08 -48.23 79.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.731 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.4 -31.37 72.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.51 74.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.482 -0.761 . . . . 0.0 110.577 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.9 ' HA ' ' CE2' ' B' ' 44' ' ' TYR . 34.4 m -72.11 -35.61 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.144 -0.973 . . . . 0.0 111.054 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.429 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -68.25 -43.64 77.4 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.522 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.74 74.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 111.724 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.9 ' CE2' ' HA ' ' B' ' 41' ' ' VAL . 0.2 OUTLIER -72.57 -39.29 67.53 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.045 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.668 ' HG ' ' CE1' ' B' ' 44' ' ' TYR . 1.3 mt -56.79 -28.77 61.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.792 -1.192 . . . . 0.0 109.751 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -73.82 -39.36 64.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -54.8 -49.67 70.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.91 -20.04 59.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.52 91.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -28.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.068 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.293 179.909 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.249 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -122.07 139.41 53.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 110.183 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 45.2 p -88.07 133.78 33.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 110.15 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.664 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -97.11 148.93 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.902 . . . . 0.0 109.697 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.13 115.55 23.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.759 ' CH2' HD11 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -118.53 114.14 22.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.948 -1.095 . . . . 0.0 111.36 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.525 ' O ' ' ND2' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -108.71 117.13 33.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.491 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.87 154.13 25.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.472 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -99.48 131.68 45.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.749 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 13.7 m -137.84 164.42 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.695 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.982 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -74.4 121.22 84.73 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.923 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HB3' HG21 ' B' ' 4' ' ' VAL . 48.5 Cg_endo -43.01 -13.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.575 1.302 . . . . 0.0 111.412 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 11' ' ' SER . 16.9 t70 -73.22 -28.53 62.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.119 . . . . 0.0 110.366 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.071 HG11 ' OE1' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -76.25 -35.86 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -48.94 70.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -57.9 -39.27 77.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -68.55 -37.86 80.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.33 -42.85 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.804 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.9 mtp180 -63.74 -41.29 98.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 109.663 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.64 -42.46 98.93 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.941 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 1.4 t80 -59.0 -51.14 71.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 111.134 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -60.62 -38.81 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.075 . . . . 0.0 110.128 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.82 59.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 109.713 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.46 -28.17 59.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.331 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.628 ' O ' ' C ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -96.67 18.51 14.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.527 -0.733 . . . . 0.0 109.853 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -18.76 119.68 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.23 -39.01 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.85 34.44 56.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.64 146.9 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -1.177 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -46.28 120.92 3.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.068 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 35' ' ' ARG . . . 123.64 110.67 1.95 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 39.2 t0 -109.72 -107.36 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.026 HD23 ' N ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -73.52 -49.55 25.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.011 -1.056 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 1.026 ' N ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -54.28 -37.45 64.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 111.149 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.675 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.79 -35.69 79.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.675 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 1.8 t80 -56.31 -49.43 74.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.684 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.716 ' CD1' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.52 -37.84 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.832 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 1.064 ' OE1' HG11 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -56.94 -47.94 79.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.757 -179.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.29 -30.4 69.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.222 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.95 65.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.295 -0.878 . . . . 0.0 111.029 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.716 HG13 ' CD1' ' A' ' 37' ' ' ILE . 18.4 m -72.5 -35.33 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.054 -1.028 . . . . 0.0 111.058 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -67.14 -43.13 83.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.043 -1.036 . . . . 0.0 110.883 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . -67.06 -46.57 73.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 111.141 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.719 ' HH ' ' HE2' ' B' ' 44' ' ' TYR . 5.2 m-85 -70.8 -49.54 45.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 111.385 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.1 mt -58.87 -42.28 89.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -65.97 -27.44 68.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.008 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -74.22 -41.52 61.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.097 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 0.2 OUTLIER -75.6 -20.38 58.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.843 . . . . 0.0 110.082 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.98 -47.14 63.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.25 -43.96 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.207 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.248 0.547 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -122.37 139.23 54.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.165 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.468 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 44.3 p -87.86 133.97 33.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -97.3 148.99 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 115.39 23.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.761 ' CH2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.48 114.14 22.41 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.393 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 7' ' ' ASN . 0.4 OUTLIER -108.72 116.86 32.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.549 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -138.64 154.2 26.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.486 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -99.35 131.6 45.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.804 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.664 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 13.6 m -137.74 164.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.791 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.981 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -74.46 121.13 84.52 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.052 -1.03 . . . . 0.0 109.856 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.3 Cg_endo -42.8 -13.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.52 1.273 . . . . 0.0 111.361 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' B' ' 11' ' ' SER . 17.0 t70 -73.2 -28.3 62.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.985 -1.072 . . . . 0.0 110.423 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.064 HG11 ' OE1' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -76.16 -35.8 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.439 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.55 -49.02 70.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -57.92 -39.24 77.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -68.53 -37.97 80.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 110.047 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.31 -42.72 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.806 ' O ' HG13 ' B' ' 22' ' ' ILE . 7.8 mtp180 -63.87 -41.23 97.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.923 . . . . 0.0 109.638 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.72 -42.3 98.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.928 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' B' ' 22' ' ' ILE . 1.4 t80 -59.12 -50.79 72.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.9 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.806 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.6 OUTLIER -60.95 -38.61 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.862 -1.149 . . . . 0.0 110.123 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.69 -29.62 59.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.995 . . . . 0.0 109.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.36 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.29 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.63 ' O ' ' C ' ' B' ' 26' ' ' GLY . 0.6 OUTLIER -96.56 18.68 13.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.713 . . . . 0.0 109.894 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.63 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -18.85 119.38 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.94 -38.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.27 56.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.37 146.92 24.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -1.202 . . . . 0.0 110.18 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -46.21 121.14 3.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.067 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' B' ' 35' ' ' ARG . . . 123.5 111.2 1.99 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 35' ' ' ARG . 36.6 t0 -110.24 -107.55 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -1.182 . . . . 0.0 110.346 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.022 HD23 ' N ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -73.29 -49.52 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.421 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 1.022 ' N ' HD23 ' B' ' 33' ' ' LEU . 3.9 m -54.29 -37.87 65.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.118 -0.989 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.672 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -67.35 -35.74 79.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.955 -1.091 . . . . 0.0 110.253 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.672 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 1.7 t80 -56.17 -49.67 73.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.656 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.713 ' CD1' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.41 -37.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.934 -1.104 . . . . 0.0 110.69 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 1.071 ' OE1' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -56.8 -47.98 78.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.768 -178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -68.42 -30.24 69.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.93 65.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.318 -0.863 . . . . 0.0 110.963 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.713 HG13 ' CD1' ' B' ' 37' ' ' ILE . 18.1 m -72.46 -35.33 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.074 -1.017 . . . . 0.0 111.033 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -67.12 -43.19 83.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.043 -1.036 . . . . 0.0 110.9 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' B' ' 47' ' ' GLU . . . -66.99 -46.47 74.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 111.162 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.719 ' HE2' ' HH ' ' A' ' 44' ' ' TYR . 5.3 m-85 -70.83 -49.68 43.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.097 -1.002 . . . . 0.0 111.426 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 41' ' ' VAL . 19.7 mt -58.86 -42.16 88.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.103 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.568 ' HB3' ' O ' ' B' ' 42' ' ' ARG . 0.5 OUTLIER -66.08 -27.46 68.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.277 -0.89 . . . . 0.0 109.906 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' B' ' 43' ' ' ALA . 1.2 mt-10 -74.25 -41.58 61.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.368 -0.832 . . . . 0.0 110.053 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 48' ' ' ARG . 0.2 OUTLIER -75.54 -20.24 58.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.02 -47.01 63.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 110.157 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.28 -43.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.225 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -140.94 121.45 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.11 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 p -58.46 129.49 42.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.313 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 2.1 t -103.61 149.92 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 0.0 109.873 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -104.55 135.03 46.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 109.219 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.923 ' CZ2' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -129.34 113.36 14.87 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.322 -179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.63 119.17 38.37 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.207 -0.933 . . . . 0.0 108.901 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.0 OUTLIER -139.35 168.82 17.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.694 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.78 137.72 43.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.381 -0.824 . . . . 0.0 110.714 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.879 ' HB ' HG21 ' A' ' 14' ' ' VAL . 31.9 m -141.1 159.26 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.97 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.16 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.2 t -76.22 132.23 73.77 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.975 . . . . 0.0 109.912 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -43.34 -12.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.876 1.461 . . . . 0.0 111.549 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.6 m-20 -72.97 -27.49 61.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.935 -1.103 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.16 HG22 ' O ' ' A' ' 11' ' ' SER . 3.8 m -73.75 -40.11 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.424 -0.798 . . . . 0.0 110.817 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.2 -48.55 64.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.835 -1.166 . . . . 0.0 109.842 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -58.36 -46.03 87.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 110.168 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.561 ' HB3' HD22 ' B' ' 45' ' ' LEU . 44.7 m -63.76 -40.49 96.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.019 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 33' ' ' LEU . 39.2 t -59.9 -43.76 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.8 tmm_? -57.91 -45.98 85.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 109.73 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 58.1 mtt -63.04 -42.79 99.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.54 -51.26 70.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.912 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -69.54 -39.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.829 -1.17 . . . . 0.0 110.381 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.1 55.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.086 . . . . 0.0 109.326 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.24 58.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.468 -0.77 . . . . 0.0 109.249 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.673 ' O ' ' C ' ' A' ' 26' ' ' GLY . 39.4 tp60 -99.08 -1.2 40.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.526 -0.734 . . . . 0.0 110.207 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.673 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -3.04 110.97 0.01 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 29' ' ' ARG . . . -149.3 23.43 1.23 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.18 -58.47 0.41 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.46 49.93 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -1.211 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' A' ' 31' ' ' GLY . 24.8 mtmt -82.4 61.27 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 109.572 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . -31.84 146.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' A' ' 34' ' ' SER . 10.7 p-10 -58.75 -148.51 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.185 -1.185 . . . . 0.0 110.021 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.731 ' CD1' HG11 ' A' ' 18' ' ' VAL . 4.0 mm? -73.18 -33.44 65.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 110.277 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' A' ' 32' ' ' ASP . 55.8 p -53.41 -44.81 69.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 110.933 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -70.71 -41.0 72.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.846 -1.159 . . . . 0.0 110.49 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' HG22 ' A' ' 18' ' ' VAL . 2.5 t80 -56.78 -49.44 75.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.868 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.612 HG13 HD13 ' B' ' 37' ' ' ILE . 2.4 tt -75.32 -39.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.002 -1.061 . . . . 0.0 110.925 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 37' ' ' ILE . 11.4 tt0 -57.35 -48.16 79.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.885 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.56 -31.06 70.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.219 -0.925 . . . . 0.0 110.136 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.77 67.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 110.817 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 42' ' ' ARG . 16.2 m -72.55 -35.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.92 . . . . 0.0 110.567 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' HG23 ' A' ' 41' ' ' VAL . 4.4 tpt180 -66.19 -43.01 88.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.465 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.9 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.289 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.56 -42.86 73.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' OG ' ' B' ' 17' ' ' SER . 69.2 mt -60.66 -38.83 86.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.25 -39.72 93.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.64 -39.27 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLU . 3.9 mtp85 -74.19 -22.61 59.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.07 96.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.427 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' HG3' ' A' ' 51' ' ' GLU . 2.0 t -64.58 -51.22 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HG3' HG12 ' A' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.4 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.233 0.54 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.33 147.85 30.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.256 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.9 p -81.72 140.26 34.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.046 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 t -102.65 148.25 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.915 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -83.65 136.11 34.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.64 ' NE1' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -112.98 141.63 46.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.76 111.48 13.71 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.003 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 37' ' ' ILE . 4.4 pt -141.13 143.19 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.864 -1.148 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -104.58 128.49 52.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.873 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.82 ' HB ' HG11 ' B' ' 14' ' ' VAL . 3.7 m -138.93 164.83 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.182 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.614 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -77.2 147.69 76.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.0 109.945 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.627 ' N ' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -53.2 -8.56 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.94 1.495 . . . . 0.0 110.678 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.638 ' OD1' HG13 ' B' ' 14' ' ' VAL . 10.9 p-10 -71.8 -25.61 62.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.194 -0.941 . . . . 0.0 109.371 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.923 ' O ' HG23 ' B' ' 18' ' ' VAL . 3.1 m -70.55 -41.58 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.678 -0.639 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.526 ' N ' HG23 ' B' ' 14' ' ' VAL . 0.5 OUTLIER -67.44 -48.55 66.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -45.29 88.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.423 ' OG ' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.55 -40.08 94.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 14' ' ' VAL . 75.2 t -59.46 -41.39 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.699 ' O ' HG13 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -64.63 -40.34 95.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mmt -63.1 -43.12 99.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.78 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -57.46 -51.32 69.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.977 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.2 pp -62.25 -38.42 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.016 -1.053 . . . . 0.0 110.034 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.59 -30.99 61.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.442 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.81 -29.57 58.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.458 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -96.93 -2.23 44.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.433 -0.792 . . . . 0.0 110.312 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.27 -135.49 7.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.29 -79.4 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.18 176.21 0.84 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HD3' ' B' ' 30' ' ' LYS . 3.6 mmt180 -130.2 -69.02 0.68 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.254 -1.144 . . . . 0.0 110.699 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' B' ' 29' ' ' ARG . 1.0 OUTLIER -60.34 179.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 41.74 54.14 4.29 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.502 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -100.05 -81.56 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -1.154 . . . . 0.0 110.371 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.923 HD23 ' CZ2' ' A' ' 6' ' ' TRP . 6.0 mp -73.65 -51.06 18.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 110.393 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 0.3 OUTLIER -60.31 -38.14 82.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 111.722 -178.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -70.73 -40.8 72.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.222 . . . . 0.0 111.109 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -55.51 -50.22 70.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 110.592 -179.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.625 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -71.04 -34.61 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 110.323 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -57.53 -48.03 80.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.841 -179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -67.78 -31.24 71.0 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.51 77.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 0.0 110.729 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.625 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.4 m -72.05 -34.72 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.676 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.404 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -65.36 -43.09 91.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 0.0 110.611 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' B' ' 46' ' ' PHE . . . -64.41 -38.39 90.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.733 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.51 -41.02 76.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 0.0 110.533 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 17' ' ' SER . 76.7 mt -71.05 -28.77 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.8 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -74.31 -45.68 45.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.029 -1.044 . . . . 0.0 110.387 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 20.4 tp10 -60.53 -50.4 73.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.454 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.474 ' O ' ' OXT' ' B' ' 51' ' ' GLU . 0.0 OUTLIER -66.68 -16.77 64.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.285 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.26 -43.76 81.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.515 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.5 OUTLIER -63.44 -42.21 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.515 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.21 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -158.09 132.79 8.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.252 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.3 p -54.24 137.84 40.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.65 148.02 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.318 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -97.85 123.47 41.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 110.153 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' B' ' 33' ' ' LEU . 1.7 m95 -93.78 140.77 29.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -128.64 112.27 14.08 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.621 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 0.4 OUTLIER -142.09 145.85 23.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.677 -178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.58 132.8 50.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 14' ' ' VAL . 2.9 m -142.27 164.04 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.34 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.6 t -77.4 140.49 64.86 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 46.9 Cg_endo -51.83 -6.66 0.18 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 123.69 1.363 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -73.27 -33.47 65.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 11' ' ' SER . 0.8 OUTLIER -75.34 -36.05 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 110.731 -179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -48.65 74.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -42.82 85.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.203 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -39.51 93.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' HB3' ' A' ' 33' ' ' LEU . 4.8 t -59.39 -43.06 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 1.8 ttt180 -67.83 -37.23 81.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.965 . . . . 0.0 109.736 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -61.44 -43.41 98.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.62 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.27 -50.33 73.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.728 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 26' ' ' GLY . 31.6 pt -64.06 -39.33 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.519 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.45 -35.14 65.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.057 -1.027 . . . . 0.0 109.581 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -28.73 58.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -100.23 -2.11 34.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.745 . . . . 0.0 110.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 120.57 -90.47 0.47 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.26 139.42 4.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.43 -179.18 22.41 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.72 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -1.174 . . . . 0.0 110.298 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -112.42 83.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 106.19 0.58 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -99.27 -69.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -1.162 . . . . 0.0 110.027 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.982 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -68.4 -42.69 78.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.0 110.585 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.579 ' HB2' HG22 ' B' ' 8' ' ' ILE . 0.9 OUTLIER -54.0 -43.94 70.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.016 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -36.96 73.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.895 -1.128 . . . . 0.0 110.428 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.686 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -56.11 -45.06 79.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -75.29 -34.51 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.136 -0.977 . . . . 0.0 110.431 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 37' ' ' ILE . 3.1 tt0 -57.23 -48.21 79.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.88 -30.95 67.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.4 74.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.404 -0.81 . . . . 0.0 110.976 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.688 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 27.5 m -71.24 -34.35 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.993 . . . . 0.0 110.562 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -64.87 -42.54 94.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.73 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 1.1 m-85 -67.33 -41.06 85.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 45' ' ' LEU . 53.7 mt -65.36 -27.92 68.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -73.93 -43.47 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.419 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.8 -39.24 84.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.917 . . . . 0.0 110.477 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 44' ' ' TYR . 1.3 mpt_? -78.25 -14.27 59.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' LEU . . . -69.81 -50.72 40.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.864 . . . . 0.0 110.222 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.04 -35.59 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 13.1 pt-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.327 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.25 0.548 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.01 133.33 8.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 24.6 p -55.0 138.14 44.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.62 148.06 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.199 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -97.62 123.29 41.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.319 -0.863 . . . . 0.0 110.052 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.625 ' CH2' ' HB2' ' A' ' 33' ' ' LEU . 1.7 m95 -93.58 140.59 29.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.089 -1.007 . . . . 0.0 110.464 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -128.56 112.27 14.13 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 0.5 OUTLIER -142.08 145.74 23.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.582 -178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.56 132.66 50.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 109.968 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 14' ' ' VAL . 2.9 m -142.09 163.66 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.882 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.7 t -77.01 140.71 66.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 47.7 Cg_endo -52.03 -6.53 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.57 1.3 . . . . 0.0 111.092 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.0 OUTLIER -73.39 -33.5 65.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.071 -1.018 . . . . 0.0 110.105 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.882 HG22 ' O ' ' B' ' 11' ' ' SER . 0.8 OUTLIER -75.22 -36.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -0.82 . . . . 0.0 110.78 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.39 -48.68 74.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.935 -1.103 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -42.78 85.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 110.14 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.8 -39.55 93.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.155 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.981 HG11 ' HB3' ' B' ' 33' ' ' LEU . 4.7 t -59.3 -43.29 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.112 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.53 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 1.7 ttt180 -67.76 -37.1 81.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.78 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' B' ' 20' ' ' MET . 0.0 OUTLIER -61.45 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.826 . . . . 0.0 109.626 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.35 -50.24 73.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.74 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' B' ' 26' ' ' GLY . 31.3 pt -64.2 -39.35 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 110.207 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.52 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.42 -34.97 64.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 109.658 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.78 -28.62 58.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.402 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -100.41 -2.21 33.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 120.61 -90.32 0.46 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.93 139.39 4.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.3 -178.99 22.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.79 -13.96 9.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -1.144 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -112.37 84.02 1.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.91 106.12 0.56 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.39 -69.07 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -1.116 . . . . 0.0 109.966 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.981 ' HB3' HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -68.49 -42.61 78.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 110.543 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -54.08 -43.94 70.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 110.941 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -36.83 73.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.882 -1.136 . . . . 0.0 110.443 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -56.17 -45.08 79.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.903 . . . . 0.0 110.259 -179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.826 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -75.35 -34.37 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.4 ' N ' HG23 ' B' ' 37' ' ' ILE . 3.0 tt0 -57.36 -48.21 79.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.983 -1.073 . . . . 0.0 110.76 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -70.9 -30.88 67.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.22 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.16 -46.49 73.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.481 -0.762 . . . . 0.0 110.894 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.686 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 27.4 m -71.11 -34.47 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -64.66 -42.46 95.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.45 83.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' B' ' 48' ' ' ARG . 1.1 m-85 -67.53 -41.3 84.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 58.2 mt -65.32 -27.71 68.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.12 -43.59 56.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 110.42 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -39.25 84.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.524 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' B' ' 44' ' ' TYR . 1.3 mpt_? -78.04 -14.44 59.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.236 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' B' ' 45' ' ' LEU . . . -70.11 -51.27 32.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.36 -34.93 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.148 -0.97 . . . . 0.0 110.203 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' B' ' 51' ' ' GLU . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.241 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.217 0.532 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' THR . 4.9 t-20 -152.29 155.61 38.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.182 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 58.7 p -86.37 140.33 30.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.893 . . . . 0.0 110.311 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 9.1 t -100.83 148.85 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.22 111.36 22.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.935 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.748 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.3 OUTLIER -95.32 138.9 32.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.057 -1.027 . . . . 0.0 110.663 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.12 112.69 15.47 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.122 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.728 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 12.6 pt -141.72 148.2 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -106.53 136.14 46.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 109.699 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' A' ' 14' ' ' VAL . 12.5 m -142.19 159.74 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.0 110.593 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.4 t -75.14 147.84 83.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 109.757 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -58.11 -3.43 1.18 Allowed 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 123.713 1.375 . . . . 0.0 111.007 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.65 67.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.07 . . . . 0.0 109.871 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -72.11 -37.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.74 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -67.04 -48.12 69.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.075 -1.016 . . . . 0.0 110.027 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.52 -47.78 81.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.263 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.616 ' HB3' HD13 ' B' ' 45' ' ' LEU . 2.7 m -63.93 -36.88 85.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -0.993 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 14' ' ' VAL . 23.7 t -59.76 -45.85 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.659 ' O ' HG13 ' A' ' 22' ' ' ILE . 2.7 mtp180 -62.5 -33.61 75.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.774 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.1 mmt -68.77 -44.24 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CE2' ' HD2' ' B' ' 48' ' ' ARG . 40.1 t80 -57.62 -50.99 71.31 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.252 -0.905 . . . . 0.0 111.217 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -56.75 -37.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 0.0 110.082 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.81 64.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.855 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.15 -27.23 60.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.327 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -98.65 0.43 44.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 110.039 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 77.71 145.71 2.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.56 -115.72 1.77 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.6 -33.36 6.64 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 170.51 8.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.309 -1.112 . . . . 0.0 110.164 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -111.69 179.55 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' LYS . . . 43.27 60.37 3.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -118.48 -7.43 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -1.086 . . . . 0.0 110.237 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -70.51 -49.83 44.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -54.84 -37.86 66.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.363 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.02 74.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.029 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.69 -45.93 81.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.848 . . . . 0.0 110.241 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -75.33 -37.82 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.524 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -57.28 -47.17 82.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.495 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -66.18 -29.8 70.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.157 -0.964 . . . . 0.0 109.867 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -70.11 -46.37 64.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.577 -0.702 . . . . 0.0 111.188 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 38' ' ' GLU . 10.8 m -70.55 -35.01 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 110.544 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -66.31 -39.79 89.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.451 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.05 87.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.63 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 3.2 m-30 -69.92 -43.08 72.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' B' ' 17' ' ' SER . 74.2 mt -60.68 -36.04 77.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.574 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -66.43 -35.36 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -62.91 -39.21 93.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.565 ' HD2' ' CE2' ' B' ' 21' ' ' PHE . 0.0 OUTLIER -80.72 -13.89 58.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.27 69.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 109.948 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -42.73 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.223 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.304 0.574 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' B' ' 3' ' ' THR . 4.7 t-20 -152.64 155.08 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 0.0 110.128 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.452 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 47.4 p -86.08 141.31 29.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.37 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 9.1 t -101.04 148.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 110.22 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.06 111.09 22.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.861 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.753 ' CZ2' HD11 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -95.02 138.85 32.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.667 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.08 112.67 15.46 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.111 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 12.4 pt -141.73 148.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.848 -1.157 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -106.86 136.16 47.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' B' ' 14' ' ' VAL . 13.7 m -142.09 161.09 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.549 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.775 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.5 t -76.39 147.7 79.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.845 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.77 -3.49 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.689 1.362 . . . . 0.0 111.035 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.79 -36.6 67.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.927 -1.108 . . . . 0.0 109.946 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -72.19 -37.1 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.494 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.11 -48.16 68.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.952 -1.092 . . . . 0.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -57.47 -47.92 80.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 110.2 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.618 ' HB3' HD22 ' A' ' 45' ' ' LEU . 2.4 m -63.93 -36.75 84.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.711 HG23 ' O ' ' B' ' 14' ' ' VAL . 24.3 t -59.78 -46.09 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.656 ' O ' HG13 ' B' ' 22' ' ' ILE . 2.7 mtp180 -62.41 -33.51 74.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmt -68.86 -44.21 73.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 109.96 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.565 ' CE2' ' HD2' ' A' ' 48' ' ' ARG . 39.8 t80 -57.71 -50.81 71.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 111.179 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.656 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.5 OUTLIER -56.97 -37.74 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.059 -1.026 . . . . 0.0 110.112 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -35.77 64.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.794 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.36 60.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.427 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -98.49 -0.27 43.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.552 -0.717 . . . . 0.0 110.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 78.7 145.93 3.07 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.44 -116.04 1.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.68 -33.79 6.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.99 170.61 8.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -1.096 . . . . 0.0 110.155 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 0.9 OUTLIER -111.8 179.43 4.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.298 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' B' ' 30' ' ' LYS . . . 43.33 60.43 3.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.4 OUTLIER -118.53 -7.36 10.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -1.147 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -70.36 -49.87 44.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 109.929 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.896 ' N ' HD23 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -54.77 -37.79 66.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -36.19 74.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 109.969 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -56.65 -45.9 81.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 110.227 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -75.46 -37.77 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.058 -1.026 . . . . 0.0 110.468 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.517 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.9 OUTLIER -57.32 -47.13 82.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.428 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -66.13 -29.75 70.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.811 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -70.11 -46.45 64.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.503 -0.748 . . . . 0.0 111.126 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.517 HG22 ' O ' ' B' ' 38' ' ' GLU . 10.2 m -70.4 -35.1 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 110.492 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.1 OUTLIER -66.22 -39.89 89.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.995 . . . . 0.0 110.485 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.91 87.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 110.786 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' B' ' 44' ' ' TYR . 3.2 m-30 -70.0 -43.14 72.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 17' ' ' SER . 76.8 mt -60.6 -35.81 77.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.513 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.92 -35.56 80.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.64 -38.87 91.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.556 ' HD2' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -81.22 -13.86 58.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.485 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.26 -48.77 72.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 109.931 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.408 HG12 ' N ' ' B' ' 51' ' ' GLU . 0.9 OUTLIER -63.96 -43.76 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.918 . . . . 0.0 109.99 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.408 ' N ' HG12 ' B' ' 50' ' ' VAL . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.083 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.253 0.549 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.84 7.9 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.548 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.8 p -55.98 138.92 48.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 15.0 t -99.62 149.15 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.897 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tpp85 -88.71 110.46 21.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.725 ' HE3' HD11 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -94.5 142.1 27.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.1 -1.0 . . . . 0.0 110.726 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -127.43 113.34 16.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.063 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.724 HD11 ' HE3' ' B' ' 6' ' ' TRP . 11.9 pt -141.58 148.62 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.648 -1.282 . . . . 0.0 111.076 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -102.46 129.01 48.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.89 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' B' ' 6' ' ' TRP . 10.0 m -141.83 164.46 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -0.981 . . . . 0.0 110.557 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -74.57 147.06 84.39 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.009 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 46.9 Cg_endo -63.5 -9.75 19.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.902 1.475 . . . . 0.0 110.597 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.82 ' OD1' HG13 ' A' ' 14' ' ' VAL . 21.7 p-10 -72.58 -27.3 62.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.545 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.82 HG13 ' OD1' ' A' ' 13' ' ' ASP . 1.8 m -74.41 -32.85 31.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.699 -0.626 . . . . 0.0 110.539 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 21.5 t0 -67.04 -48.05 69.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.173 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 27.8 mm-40 -57.3 -39.3 75.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.105 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.836 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -63.92 -38.79 92.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.083 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG11 HD22 ' A' ' 33' ' ' LEU . 50.0 t -59.48 -44.06 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.45 -43.97 95.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.155 -0.966 . . . . 0.0 110.177 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 mtt -61.54 -43.77 98.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.854 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -59.08 -50.47 73.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 110.79 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 19' ' ' ARG . 39.0 pt -60.74 -38.78 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -55.02 -27.77 46.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -26.69 58.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.199 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' A' ' 26' ' ' GLY . 4.1 mt-30 -106.97 18.23 22.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.555 -0.716 . . . . 0.0 109.846 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -30.74 113.16 0.05 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.92 -64.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' C ' ' HG3' ' A' ' 29' ' ' ARG . . . -128.87 179.73 16.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' LYS . 2.1 mtp180 -125.63 12.41 8.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -1.131 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 29' ' ' ARG . 22.4 mmmt -59.85 -124.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 35' ' ' ARG . . . -52.57 131.21 39.27 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.94 -91.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -1.149 . . . . 0.0 110.349 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.16 -49.29 29.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.391 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 40.1 m -53.68 -46.08 70.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 111.074 -178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 2.1 mmp_? -70.34 -40.16 74.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.769 -1.207 . . . . 0.0 110.542 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.69 -47.81 76.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 110.526 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.13 -37.88 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.056 -1.028 . . . . 0.0 110.384 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 34' ' ' SER . 4.5 tm-20 -57.29 -48.24 79.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 110.932 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -68.94 -31.39 70.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.03 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.36 75.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.323 -0.86 . . . . 0.0 110.546 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 38' ' ' GLU . 26.6 m -72.27 -34.87 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.535 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -63.32 -38.66 92.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 110.292 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.32 97.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -70.65 -46.3 63.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' B' ' 17' ' ' SER . 24.3 mt -62.42 -33.78 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -73.7 -41.43 62.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.925 . . . . 0.0 110.159 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -41.52 92.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG2' ' NH1' ' A' ' 48' ' ' ARG . 15.7 ttt-85 -70.95 -22.4 62.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.45 -51.83 39.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.07 -49.75 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG3' ' OXT' ' A' ' 51' ' ' GLU . 36.9 tp10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.236 0.541 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -149.32 7.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -55.73 139.97 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.066 -1.021 . . . . 0.0 110.028 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 15.2 t -100.13 149.13 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.762 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 8.9 tpp85 -88.45 110.41 20.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.724 ' HE3' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -94.61 141.94 28.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 0.0 110.719 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.4 113.21 15.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 ' HE3' ' A' ' 6' ' ' TRP . 11.5 pt -141.56 148.86 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.771 -1.205 . . . . 0.0 110.968 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -102.79 128.82 49.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 6' ' ' TRP . 9.9 m -141.43 164.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.157 -0.964 . . . . 0.0 110.617 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.629 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.1 m -74.35 147.03 84.88 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 47.6 Cg_endo -63.37 -9.76 18.95 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.866 1.456 . . . . 0.0 110.578 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.819 ' OD1' HG13 ' B' ' 14' ' ' VAL . 22.1 p-10 -72.59 -27.33 62.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 109.527 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.819 HG13 ' OD1' ' B' ' 13' ' ' ASP . 1.8 m -74.41 -32.93 32.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.694 -0.629 . . . . 0.0 110.523 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 21.1 t0 -66.89 -48.15 69.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 28.2 mm-40 -57.39 -39.14 75.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.823 ' HB3' HD22 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -63.86 -38.86 92.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 110.099 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.85 HG11 HD22 ' B' ' 33' ' ' LEU . 50.1 t -59.46 -44.14 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.422 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.545 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.39 -43.91 96.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.223 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.2 mtt -61.58 -43.78 98.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.86 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -59.22 -50.5 73.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.762 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.5 pt -60.52 -38.79 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.998 -1.064 . . . . 0.0 110.1 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.53 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.17 -27.72 47.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.7 58.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.403 -0.811 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' B' ' 26' ' ' GLY . 4.2 mt-30 -106.95 18.26 22.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.535 -0.728 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -30.71 112.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.61 -65.05 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' B' ' 29' ' ' ARG . . . -128.4 179.97 16.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.469 ' O ' ' O ' ' B' ' 30' ' ' LYS . 2.2 mtp180 -125.82 12.6 7.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.351 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' B' ' 29' ' ' ARG . 22.6 mmmt -59.95 -124.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.139 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' B' ' 35' ' ' ARG . . . -52.5 131.1 38.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -110.85 -91.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -1.092 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.85 HD22 HG11 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -73.2 -49.4 28.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.305 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 47.0 m -53.67 -46.08 70.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 111.102 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HG3' ' HA3' ' B' ' 31' ' ' GLY . 2.0 mmp_? -70.31 -40.14 74.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.84 -1.163 . . . . 0.0 110.526 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -47.8 76.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.16 -37.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.102 -0.998 . . . . 0.0 110.401 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 34' ' ' SER . 4.5 tm-20 -57.31 -48.2 79.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.982 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.89 -31.46 70.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.986 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.34 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 110.547 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 38' ' ' GLU . 26.5 m -72.18 -34.97 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.566 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' PHE . 0.3 OUTLIER -63.4 -38.65 91.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.15 -0.969 . . . . 0.0 110.248 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.4 97.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 110.481 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.71 -46.24 63.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.726 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.836 HD22 ' HB3' ' A' ' 17' ' ' SER . 24.5 mt -62.54 -33.73 75.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.569 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -73.71 -41.44 62.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.19 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.48 -41.73 92.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 110.24 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 15.4 ttt-85 -70.85 -22.2 62.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.61 -52.33 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.68 -49.0 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.464 ' HG3' ' OXT' ' B' ' 51' ' ' GLU . 37.5 tp10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.252 0.549 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.605 ' O ' ' HD3' ' B' ' 12' ' ' PRO . 0.5 OUTLIER -157.75 -45.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.0 p -49.38 120.63 4.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 7.6 t -98.93 148.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.855 . . . . 0.0 110.107 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -85.58 113.92 22.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.928 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.772 ' HB2' ' O ' ' B' ' 8' ' ' ILE . 0.6 OUTLIER -100.62 139.84 35.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.992 -1.068 . . . . 0.0 110.681 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.37 113.14 15.85 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.045 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 ' O ' ' HB2' ' B' ' 6' ' ' TRP . 11.3 pt -141.79 148.93 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.66 -1.275 . . . . 0.0 111.338 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 109.894 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG21 ' A' ' 14' ' ' VAL . 25.0 m -142.83 163.98 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.188 -0.945 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -72.72 133.1 82.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.972 . . . . 0.0 110.132 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 2' ' ' ASN . 49.6 Cg_endo -50.69 -14.72 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.02 1.537 . . . . 0.0 110.959 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -72.54 -27.7 62.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.058 -1.026 . . . . 0.0 109.437 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -75.97 -34.95 28.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.641 -0.662 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 60.8 t0 -67.15 -48.62 67.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.173 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 17' ' ' SER . 12.6 pt20 -57.26 -35.43 69.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -75.28 -34.16 61.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.096 -1.003 . . . . 0.0 109.839 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 14' ' ' VAL . 27.8 t -61.21 -43.18 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.425 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 23.1 mtt180 -62.17 -45.34 93.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.056 -1.028 . . . . 0.0 109.779 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.0 mtm -61.12 -42.35 98.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -0.957 . . . . 0.0 109.573 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.72 -50.54 72.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.819 . . . . 0.0 110.715 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 19' ' ' ARG . 21.7 pt -62.0 -38.78 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.086 . . . . 0.0 110.022 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.02 -30.02 61.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.179 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.28 58.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.32 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -100.17 -2.33 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.46 -0.775 . . . . 0.0 109.976 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 66.13 179.14 9.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.13 23.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.24 -33.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.57 159.2 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -1.13 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -44.87 -37.1 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.17 128.86 37.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.63 -111.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -1.146 . . . . 0.0 110.214 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -64.42 -37.26 86.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' ILE . 22.8 t -54.47 -33.71 60.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.0 -36.16 74.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 1.0 OUTLIER -56.32 -46.3 79.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.288 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -75.15 -37.29 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.353 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.33 -48.03 80.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.577 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.18 -30.9 70.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.825 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.2 -46.05 78.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 110.421 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.773 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 30.3 m -71.08 -34.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -65.5 -43.07 91.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.84 97.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -65.14 -42.87 93.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' B' ' 17' ' ' SER . 44.4 mt -62.33 -35.46 79.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 1.4 t80 -69.95 -45.23 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -45.89 92.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -17.17 64.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . . . -66.91 -50.69 61.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 110.27 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -31.45 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.222 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.157 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.176 0.513 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.666 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -157.45 -46.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.436 179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 70.8 p -49.08 124.2 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 0.0 110.039 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 6.1 t -100.97 148.91 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.538 -0.726 . . . . 0.0 109.952 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.507 ' HD3' ' C ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -84.91 112.33 20.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.887 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.745 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.91 139.66 34.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.661 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -127.41 113.15 15.82 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.002 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 6' ' ' TRP . 11.2 pt -141.64 149.47 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.708 -1.245 . . . . 0.0 111.188 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -105.82 133.05 51.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.139 -0.976 . . . . 0.0 109.972 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.578 ' HB ' HG21 ' B' ' 14' ' ' VAL . 27.3 m -141.61 164.23 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.613 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -72.97 133.49 81.84 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 51.2 Cg_endo -50.64 -14.99 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.952 1.501 . . . . 0.0 110.973 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 16' ' ' GLN . 0.3 OUTLIER -72.55 -27.73 62.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.057 . . . . 0.0 109.49 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.651 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.7 m -75.92 -35.07 28.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.606 -0.684 . . . . 0.0 110.398 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.424 ' N ' ' CG2' ' B' ' 14' ' ' VAL . 60.7 t0 -67.15 -48.53 67.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.218 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.554 ' HG3' ' N ' ' B' ' 17' ' ' SER . 12.5 pt20 -57.35 -35.07 69.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 110.117 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.554 ' N ' ' HG3' ' B' ' 16' ' ' GLN . 0.8 OUTLIER -75.61 -34.08 60.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.817 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 14' ' ' VAL . 28.0 t -61.31 -43.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 110.463 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.582 ' O ' ' CG1' ' B' ' 22' ' ' ILE . 23.2 mtt180 -62.08 -45.45 93.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.734 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 12.9 mtm -61.02 -42.32 98.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.81 -50.56 72.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.458 -0.776 . . . . 0.0 110.739 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 19' ' ' ARG . 21.7 pt -61.91 -38.91 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 110.039 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.465 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -55.89 -29.9 60.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.024 -1.047 . . . . 0.0 109.196 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.22 58.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.499 -0.75 . . . . 0.0 109.221 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -100.44 -2.32 33.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.582 -0.699 . . . . 0.0 110.009 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 66.24 179.24 9.64 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.05 168.89 23.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.96 -33.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -55.63 159.48 2.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.155 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -45.07 -37.14 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.97 128.86 37.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -125.77 -112.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -1.129 . . . . 0.0 110.174 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' B' ' 33' ' ' LEU . 0.1 OUTLIER -64.31 -37.32 87.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.075 -1.015 . . . . 0.0 110.044 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.516 ' O ' HG22 ' B' ' 37' ' ' ILE . 22.8 t -54.52 -33.67 60.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.321 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.02 -36.13 74.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 110.164 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.773 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -56.38 -46.2 80.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -75.14 -37.35 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.046 -1.034 . . . . 0.0 110.346 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.484 ' N ' HG23 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -57.35 -48.12 79.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.625 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -30.7 69.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 109.815 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.26 -46.12 78.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.789 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 29.7 m -70.82 -34.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.526 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -65.58 -42.97 91.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.95 97.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 110.185 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -65.14 -42.91 93.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.382 -0.824 . . . . 0.0 110.199 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 41' ' ' VAL . 45.1 mt -62.06 -35.31 78.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' B' ' 49' ' ' ALA . 1.4 t80 -70.22 -45.48 66.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.248 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 -45.94 91.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.212 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -17.13 63.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' B' ' 46' ' ' PHE . . . -67.01 -50.61 61.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.19 -31.89 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.196 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 1' ' ' MET . 3.1 m120 -132.34 111.71 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -53.92 142.64 23.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 55.3 t -99.28 148.8 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -100.61 129.1 46.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 109.629 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.963 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.5 OUTLIER -124.4 114.12 19.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 111.192 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.435 ' C ' ' OD1' ' A' ' 7' ' ' ASN . 5.0 t-20 -107.48 117.43 34.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.453 HG13 ' OG ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -138.92 154.62 26.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.444 -179.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.46 136.41 38.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 10.0 m -141.41 163.98 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.719 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 8.0 t -76.01 145.27 77.12 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 45.9 Cg_endo -57.67 -4.46 1.35 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.546 1.287 . . . . 0.0 110.749 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 11' ' ' SER . 73.1 m-20 -73.28 -31.81 64.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.087 -1.008 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -73.97 -43.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.338 -0.851 . . . . 0.0 110.411 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -65.06 -48.06 75.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.01 -1.056 . . . . 0.0 109.585 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -57.1 -46.28 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 110.027 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -63.94 -35.51 80.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.752 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.5 t -60.01 -47.34 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.815 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.574 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.15 -30.1 70.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.646 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -66.82 -43.76 82.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.572 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 t80 -61.65 -50.86 70.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.848 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -61.35 -44.78 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.995 -1.065 . . . . 0.0 110.205 -179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.68 -36.21 64.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.661 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.48 60.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.314 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 41.6 tt0 -96.43 -2.21 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 25' ' ' GLN . . . 43.56 90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.27 -120.02 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.82 174.32 18.18 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -125.53 21.33 7.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -1.153 . . . . 0.0 110.226 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -104.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.61 41.86 1.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.654 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 2.4 p30 -76.5 -0.65 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.313 -1.11 . . . . 0.0 110.316 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.958 HD23 ' CH2' ' B' ' 6' ' ' TRP . 5.0 mp -70.06 -49.54 50.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.335 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.73 -33.53 61.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.654 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -71.25 -37.86 71.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -56.69 -46.15 81.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -71.84 -37.6 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 110.31 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.4 mt-10 -56.71 -48.11 78.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -0.951 . . . . 0.0 110.668 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -70.31 -31.18 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.115 -0.991 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.69 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.354 -0.841 . . . . 0.0 110.97 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 37' ' ' ILE . 3.7 m -68.67 -34.81 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 110.742 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -58.76 -41.81 87.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.953 . . . . 0.0 110.693 -179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.82 95.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.671 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -70.06 -50.23 43.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.073 -1.017 . . . . 0.0 110.642 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.83 -38.41 75.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 110.719 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -64.83 -44.99 88.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.324 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 32.3 tt0 -55.14 -42.09 72.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.925 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' NH2' ' CD2' ' B' ' 21' ' ' PHE . 41.6 mtp180 -80.42 -12.91 59.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.425 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.25 73.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' GLU . 24.6 t -61.1 -50.21 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 50' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.489 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.406 ' C ' ' OD1' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.257 0.551 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.406 ' OD1' ' C ' ' B' ' 1' ' ' MET . 3.1 m120 -132.17 111.82 11.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 33.0 p -53.98 142.66 24.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 55.0 t -99.31 148.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 -100.5 129.04 46.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.958 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -124.3 114.02 19.02 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.174 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' B' ' 7' ' ' ASN . 4.9 t-20 -107.41 117.32 33.77 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 109.503 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.454 HG13 ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -138.98 154.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.444 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.48 136.52 38.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.624 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 9.9 m -141.37 163.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.743 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.81 ' O ' HG22 ' B' ' 14' ' ' VAL . 8.1 t -76.17 144.01 74.41 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.977 . . . . 0.0 109.568 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 45.9 Cg_endo -56.35 -4.65 0.81 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.612 1.322 . . . . 0.0 110.821 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 11' ' ' SER . 70.5 m-20 -73.35 -31.67 64.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 110.277 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.81 HG22 ' O ' ' B' ' 11' ' ' SER . 0.2 OUTLIER -73.85 -44.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' B' ' 18' ' ' VAL . 0.1 OUTLIER -64.85 -48.09 75.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.94 -1.1 . . . . 0.0 109.672 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -56.99 -46.24 82.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 110.145 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' B' ' 20' ' ' MET . 0.3 OUTLIER -63.91 -35.69 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.806 179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.5 t -59.93 -47.29 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 109.961 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.57 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.1 OUTLIER -61.26 -30.13 70.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' B' ' 17' ' ' SER . 0.1 OUTLIER -66.78 -43.67 83.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.737 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.513 ' C ' ' CD1' ' B' ' 21' ' ' PHE . 4.4 t80 -61.69 -50.86 70.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -0.877 . . . . 0.0 110.841 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.9 OUTLIER -61.26 -44.93 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.058 -1.027 . . . . 0.0 110.18 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.08 64.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.135 -0.978 . . . . 0.0 109.697 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.78 -26.31 60.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.321 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' B' ' 26' ' ' GLY . 41.5 tt0 -96.56 -2.23 45.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 110.043 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 25' ' ' GLN . . . 43.59 89.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.86 -120.12 1.96 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.74 174.72 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -125.82 21.73 7.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.256 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -104.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.41 41.8 1.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.647 ' HA ' ' HG3' ' B' ' 35' ' ' ARG . 2.4 p30 -76.36 -0.83 24.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.129 . . . . 0.0 110.301 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.963 HD23 ' CH2' ' A' ' 6' ' ' TRP . 5.0 mp -69.99 -49.77 48.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.525 ' O ' HG22 ' B' ' 37' ' ' ILE . 0.9 OUTLIER -54.53 -33.51 60.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.468 -179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.647 ' HG3' ' HA ' ' B' ' 32' ' ' ASP . 0.1 OUTLIER -71.42 -37.86 71.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.597 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -56.82 -46.07 81.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.462 -0.774 . . . . 0.0 110.527 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.683 ' O ' HG13 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -71.65 -37.71 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.403 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.579 ' O ' HG22 ' B' ' 41' ' ' VAL . 11.6 mt-10 -56.75 -48.0 78.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.335 -0.853 . . . . 0.0 110.77 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.25 -31.34 68.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.064 -1.023 . . . . 0.0 109.934 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.53 80.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -0.806 . . . . 0.0 110.951 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.683 HG13 ' O ' ' B' ' 37' ' ' ILE . 3.8 m -68.9 -34.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.093 -1.005 . . . . 0.0 110.716 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' B' ' 42' ' ' ARG . 0.2 OUTLIER -58.75 -41.81 87.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.78 95.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -70.21 -50.14 43.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 17' ' ' SER . 23.8 mt -57.83 -38.39 75.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.252 -0.905 . . . . 0.0 110.709 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.561 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -64.93 -44.78 88.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.365 -179.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.464 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 33.1 tt0 -55.33 -41.67 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.47 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.481 ' NH2' ' CD2' ' A' ' 21' ' ' PHE . 41.2 mtp180 -80.92 -12.82 59.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 110.533 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.63 -47.62 74.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.083 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' B' ' 51' ' ' GLU . 23.5 t -61.54 -51.19 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 50' ' ' VAL . 2.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.192 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -141.85 152.46 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -89.04 136.68 32.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 86.8 t -101.8 149.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.89 . . . . 0.0 109.886 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 5' ' ' ARG . 5.4 mtm-85 -95.81 117.27 30.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.654 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.05 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.2 OUTLIER -109.58 114.15 27.52 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.94 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.53 117.02 33.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.819 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.0 OUTLIER -138.98 155.37 26.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.97 -179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -100.88 132.66 46.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 111.145 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.6 m -139.58 164.0 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.909 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.5 p -73.04 134.38 80.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.975 . . . . 0.0 110.007 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.505 ' HD3' HG23 ' B' ' 4' ' ' VAL . 46.5 Cg_endo -52.9 -10.95 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 123.343 1.18 . . . . 0.0 110.816 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.3 t70 -74.33 -29.7 61.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.1 -1.0 . . . . 0.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 11' ' ' SER . 0.4 OUTLIER -76.81 -32.46 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -66.44 -48.87 68.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.842 -1.161 . . . . 0.0 110.076 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -57.48 -36.2 71.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.0 110.272 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -74.09 -34.1 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 14' ' ' VAL . 18.3 t -60.46 -42.31 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.409 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.561 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -60.03 -45.44 92.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 109.473 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.9 mmt -61.44 -42.42 98.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.555 ' HA ' ' NH1' ' B' ' 48' ' ' ARG . 4.6 t80 -60.17 -50.52 73.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.423 -0.798 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 19' ' ' ARG . 38.6 pt -60.97 -39.94 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.286 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -56.27 -28.38 58.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 109.299 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.12 -30.18 58.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.55 -0.718 . . . . 0.0 109.591 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' O ' ' C ' ' A' ' 26' ' ' GLY . 9.8 mm100 -97.13 -2.6 42.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -0.789 . . . . 0.0 110.518 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.686 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . 10.24 92.93 0.01 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.32 -175.32 21.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 29' ' ' ARG . . . -116.97 -110.22 2.6 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 28' ' ' GLY . 57.8 mtm180 -41.22 -53.45 3.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 110.012 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 8.7 mtpm? -109.33 146.57 34.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.981 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 35' ' ' ARG . . . 148.43 13.15 0.13 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 34' ' ' SER . 3.6 p30 -88.91 -157.53 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.071 -1.253 . . . . 0.0 109.808 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 9.0 mp -73.94 -50.78 18.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 60.6 p -54.92 -41.57 71.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.358 -0.839 . . . . 0.0 111.399 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.1 -38.44 75.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 110.822 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.66 -48.61 74.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 110.509 -179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.915 ' CD1' HD12 ' B' ' 37' ' ' ILE . 3.2 tt -75.23 -36.88 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 110.483 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.0 tt0 -56.99 -47.94 79.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.893 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -70.14 -30.73 67.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.031 -1.043 . . . . 0.0 110.004 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.94 -46.07 75.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.542 -0.724 . . . . 0.0 111.131 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' A' ' 37' ' ' ILE . 2.6 m -66.35 -35.49 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.027 -1.045 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -62.26 -43.02 99.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.043 . . . . 0.0 110.671 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . . . -64.12 -38.25 90.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.481 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' B' ' 21' ' ' PHE . 1.1 m-85 -70.14 -47.59 61.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 110.669 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 41' ' ' VAL . 7.4 mt -56.71 -36.52 69.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.913 . . . . 0.0 110.923 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.66 ' CD1' ' C ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.13 -42.26 89.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.988 -1.07 . . . . 0.0 110.198 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 46' ' ' PHE . 31.6 tt0 -56.65 -42.89 79.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.004 -1.06 . . . . 0.0 110.54 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' B' ' 21' ' ' PHE . 15.6 ttm180 -72.92 -22.35 60.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.152 -0.967 . . . . 0.0 110.504 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.39 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 110.415 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.9 t -72.34 -44.27 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.241 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 12.3 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.169 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.199 0.523 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 2' ' ' ASN . 3.2 m120 -141.8 152.29 43.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 110.181 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 77.7 p -88.81 136.85 32.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 95.3 t -101.99 149.7 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.44 ' CB ' ' CZ ' ' B' ' 5' ' ' ARG . 5.6 mtm-85 -95.76 117.14 29.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.656 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -109.49 114.21 27.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.986 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.58 117.11 33.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.85 . . . . 0.0 109.765 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -138.97 155.59 27.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.343 -0.848 . . . . 0.0 109.853 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -101.11 132.79 46.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.6 m -139.7 164.2 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.784 . . . . 0.0 109.879 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.886 ' O ' HG22 ' B' ' 14' ' ' VAL . 2.6 p -73.34 134.01 80.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 110.038 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 4' ' ' VAL . 46.4 Cg_endo -52.51 -11.05 1.04 Allowed 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 123.4 1.21 . . . . 0.0 110.82 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' ' OG ' ' B' ' 17' ' ' SER . 22.6 t70 -74.21 -29.7 61.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.128 -0.982 . . . . 0.0 110.583 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.886 HG22 ' O ' ' B' ' 11' ' ' SER . 0.4 OUTLIER -76.74 -32.23 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.871 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -66.75 -48.84 67.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.844 -1.16 . . . . 0.0 110.146 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.46 -36.26 71.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 13' ' ' ASP . 0.9 OUTLIER -74.04 -34.23 64.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.753 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 14' ' ' VAL . 18.1 t -60.58 -42.24 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.316 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.558 ' O ' HG12 ' B' ' 22' ' ' ILE . 0.6 OUTLIER -59.97 -45.54 92.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.162 -0.962 . . . . 0.0 109.521 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -61.33 -42.49 98.77 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.492 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.56 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 4.8 t80 -60.02 -50.56 73.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 110.889 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.558 HG12 ' O ' ' B' ' 19' ' ' ARG . 39.0 pt -61.0 -39.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.06 -1.025 . . . . 0.0 110.243 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' B' ' 22' ' ' ILE . . . -56.24 -28.39 58.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 109.329 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.01 57.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.561 -0.712 . . . . 0.0 109.559 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.684 ' O ' ' C ' ' B' ' 26' ' ' GLY . 9.8 mm100 -97.24 -2.83 41.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.514 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.684 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . 10.51 93.06 0.01 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.52 -175.25 21.15 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' B' ' 29' ' ' ARG . . . -116.99 -110.25 2.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' B' ' 28' ' ' GLY . 57.5 mtm180 -41.28 -53.64 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.102 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' B' ' 35' ' ' ARG . 8.7 mtpm? -109.13 146.13 34.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.929 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' B' ' 35' ' ' ARG . . . 148.77 13.95 0.11 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' B' ' 34' ' ' SER . 3.6 p30 -89.76 -157.7 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.037 -1.272 . . . . 0.0 109.708 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.05 HD23 ' CH2' ' A' ' 6' ' ' TRP . 9.0 mp -73.86 -50.77 18.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.475 ' N ' ' OD1' ' B' ' 32' ' ' ASP . 60.5 p -54.93 -41.63 71.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.842 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 31' ' ' GLY . 0.0 OUTLIER -70.06 -38.43 75.78 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.912 -1.118 . . . . 0.0 110.787 -179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -55.79 -48.57 75.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.433 -179.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.915 HD12 ' CD1' ' A' ' 37' ' ' ILE . 3.1 tt -75.26 -36.82 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.063 -1.023 . . . . 0.0 110.5 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.584 ' O ' HG22 ' B' ' 41' ' ' VAL . 4.0 tt0 -57.02 -47.93 79.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.878 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -70.27 -30.88 68.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.008 . . . . 0.0 109.942 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -45.91 77.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 111.12 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.84 HG13 ' O ' ' B' ' 37' ' ' ILE . 2.6 m -66.55 -35.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.811 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 42' ' ' ARG . 0.0 OUTLIER -62.13 -43.03 99.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.079 -1.013 . . . . 0.0 110.598 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' B' ' 46' ' ' PHE . . . -64.05 -38.0 89.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.496 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 1.1 m-85 -70.42 -47.65 59.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.726 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.637 HD12 ' O ' ' B' ' 41' ' ' VAL . 7.5 mt -56.57 -36.11 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.928 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.662 ' C ' ' CD1' ' B' ' 46' ' ' PHE . 0.0 OUTLIER -66.69 -42.2 86.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 31.4 tt0 -56.63 -43.15 79.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.135 -0.978 . . . . 0.0 110.436 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.555 ' NH1' ' HA ' ' A' ' 21' ' ' PHE . 15.6 ttm180 -72.87 -21.98 60.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.148 -0.97 . . . . 0.0 110.469 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.57 77.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 51' ' ' GLU . 2.7 t -72.38 -44.28 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.323 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' B' ' 50' ' ' VAL . 12.6 tt0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.221 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.275 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.38 141.0 41.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 145.62 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.674 ' HB ' ' O ' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -101.06 149.74 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' NH1' ' CG ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -99.63 133.39 44.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 109.985 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CH2' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -131.44 113.71 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.277 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.403 ' CB ' ' OD1' ' B' ' 7' ' ' ASN . 61.0 m-20 -104.98 118.03 35.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 109.042 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.39 160.07 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.337 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.81 123.18 40.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.86 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 11.1 m -137.43 164.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.472 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.016 ' O ' HG22 ' A' ' 14' ' ' VAL . 4.7 t -80.03 130.33 66.91 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.57 -8.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.597 1.314 . . . . 0.0 111.213 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' SER . 9.8 t70 -73.11 -27.57 61.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.96 -1.088 . . . . 0.0 110.138 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.016 HG22 ' O ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -75.2 -30.51 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 110.433 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 14.9 t0 -65.65 -48.74 71.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.95 -1.094 . . . . 0.0 110.036 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.46 -40.58 83.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -70.55 -37.57 74.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.4 t -64.9 -45.1 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.495 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.623 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -65.72 -45.89 80.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -40.29 92.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -57.68 -45.19 85.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -57.35 -35.68 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 22' ' ' ILE . . . -56.27 -35.5 67.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.063 -1.023 . . . . 0.0 109.439 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 -32.58 59.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 3.8 tt0 -101.73 -1.92 31.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.394 -0.816 . . . . 0.0 110.293 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 76.93 -109.98 2.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.46 -166.78 33.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 29' ' ' ARG . . . -155.02 -144.28 3.88 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLY . 2.0 mtp180 -56.55 -162.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -1.103 . . . . 0.0 110.3 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.98 63.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ARG . . . -141.91 128.58 3.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 33' ' ' LEU . 66.5 t0 -116.3 -107.85 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -1.152 . . . . 0.0 110.118 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.842 HD13 ' CH2' ' B' ' 6' ' ' TRP . 0.1 OUTLIER -70.37 -43.87 69.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 110.296 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 3.9 t -54.94 -41.32 70.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.717 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -70.86 -38.29 73.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -42.42 80.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' B' ' 37' ' ' ILE . 0.0 OUTLIER -74.67 -37.49 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 110.426 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -57.2 -48.13 79.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.16 -0.962 . . . . 0.0 110.736 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.55 -31.35 70.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.875 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 44' ' ' TYR . . . -65.97 -45.31 82.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.556 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -68.48 -35.42 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.15 97.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.0 110.41 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.94 91.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.383 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 40' ' ' ALA . 3.3 m-30 -62.33 -44.28 96.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.2 mt -61.93 -26.0 67.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.519 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.24 -44.96 62.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.917 . . . . 0.0 110.426 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.96 -44.81 82.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -23.62 58.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.32 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.69 98.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -72.6 -43.15 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.211 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.304 0.573 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.59 140.54 41.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 4.8 p -83.54 146.1 28.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -101.47 149.82 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.618 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.518 ' NH1' ' CG ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -99.36 133.31 43.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.971 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.842 ' CH2' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.45 113.83 14.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 111.255 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.403 ' OD1' ' CB ' ' A' ' 7' ' ' ASN . 62.7 m-20 -105.25 117.76 34.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.315 -0.865 . . . . 0.0 109.046 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.94 160.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.299 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.91 123.02 40.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 110.94 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 10.9 m -137.3 164.22 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.473 -0.767 . . . . 0.0 109.524 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.014 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.9 t -79.5 130.01 69.75 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.091 -1.006 . . . . 0.0 109.964 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 4' ' ' VAL . 48.2 Cg_endo -47.44 -8.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.595 1.313 . . . . 0.0 111.24 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' B' ' 11' ' ' SER . 9.8 t70 -72.98 -27.46 61.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.144 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.014 HG22 ' O ' ' B' ' 11' ' ' SER . 0.6 OUTLIER -75.14 -30.24 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' B' ' 15' ' ' ASP . 13.1 t0 -65.88 -48.83 70.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.028 -1.045 . . . . 0.0 109.914 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -58.35 -40.65 82.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.57 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m -70.45 -37.71 74.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.695 ' O ' HG23 ' B' ' 22' ' ' ILE . 30.9 t -64.81 -45.22 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 110.553 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.622 ' O ' HG12 ' B' ' 22' ' ' ILE . 1.0 OUTLIER -65.49 -46.02 81.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -40.35 92.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.96 . . . . 0.0 110.067 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.66 -45.27 85.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.654 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.695 HG23 ' O ' ' B' ' 18' ' ' VAL . 0.6 OUTLIER -57.18 -35.65 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.0 -1.062 . . . . 0.0 110.003 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.483 ' N ' HG12 ' B' ' 22' ' ' ILE . . . -56.36 -35.62 67.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 0.0 109.325 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.61 59.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.891 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 25' ' ' GLN . 3.9 tt0 -101.67 -1.64 32.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 110.339 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' B' ' 22' ' ' ILE . . . 76.54 -110.29 2.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.94 -166.74 33.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 29' ' ' ARG . . . -154.95 -144.56 3.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' B' ' 31' ' ' GLY . 2.0 mtp180 -56.44 -162.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.04 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 29' ' ' ARG . . . -141.88 128.44 3.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.566 ' CG ' HD23 ' B' ' 33' ' ' LEU . 66.6 t0 -116.19 -107.91 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.853 HD13 ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -70.19 -44.0 69.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.024 -1.048 . . . . 0.0 110.342 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.626 ' O ' HG22 ' B' ' 37' ' ' ILE . 4.0 t -54.95 -41.29 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.738 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -70.88 -38.23 73.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.995 -1.066 . . . . 0.0 110.552 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -42.61 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.278 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.858 HG13 HG13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -74.82 -36.99 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.567 -179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.3 OUTLIER -57.28 -48.13 79.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.714 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -68.48 -31.37 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 109.933 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.586 ' O ' ' CD2' ' B' ' 44' ' ' TYR . . . -66.08 -45.06 82.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.447 -0.783 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 38' ' ' GLU . 27.4 m -68.55 -35.47 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.416 ' N ' HG23 ' B' ' 41' ' ' VAL . 1.8 ttt85 -63.65 -43.14 97.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.98 90.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' B' ' 40' ' ' ALA . 3.3 m-30 -62.35 -44.23 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.97 -25.94 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.531 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -72.38 -45.12 61.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -44.8 81.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.313 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -23.73 58.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.909 . . . . 0.0 110.32 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.98 98.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.38 -42.79 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.146 -179.814 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mmm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.3 0.572 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -112.73 114.22 26.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' B' ' 9' ' ' ALA . 40.6 p -68.92 141.27 55.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 110.273 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 2.1 t -98.18 149.56 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 109.561 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -99.2 128.63 45.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.539 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.97 115.08 21.89 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.425 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.569 ' OD1' ' ND2' ' B' ' 7' ' ' ASN . 3.1 m-20 -100.6 117.33 34.52 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -138.0 153.42 27.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.632 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -97.6 123.69 41.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.409 -0.807 . . . . 0.0 110.93 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.716 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 19.8 m -138.8 164.32 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.703 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 1.043 ' O ' HG22 ' A' ' 14' ' ' VAL . 5.0 t -76.42 128.53 82.16 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 109.86 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' B' ' 4' ' ' VAL . 46.4 Cg_endo -47.06 -8.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.666 1.35 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -73.09 -26.98 61.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 110.209 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.043 HG22 ' O ' ' A' ' 11' ' ' SER . 1.4 m -75.73 -35.46 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.425 -0.797 . . . . 0.0 110.624 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' CZ ' ' A' ' 19' ' ' ARG . 29.7 t0 -66.36 -49.41 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.051 . . . . 0.0 110.032 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -59.26 -41.17 88.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.316 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -64.13 -40.09 95.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 33' ' ' LEU . 2.4 t -58.94 -39.07 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 110.09 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.721 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.6 mtt-85 -60.97 -43.09 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.331 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.9 mtp -63.52 -43.25 97.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.948 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -59.42 -51.2 70.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.181 -0.949 . . . . 0.0 110.834 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 19' ' ' ARG . 1.9 pp -60.27 -38.91 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.011 -1.055 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -56.15 -28.05 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 0.0 109.489 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.39 -29.98 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.463 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' GLY . 19.9 mm100 -94.92 8.6 42.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 110.079 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' GLN . . . -40.85 149.97 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.54 113.86 3.7 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.69 -155.25 16.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -61.37 171.44 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -1.189 . . . . 0.0 110.233 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' GLY . 4.6 mmmt -61.65 -56.07 23.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.466 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 63.86 126.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.26 -161.88 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.169 . . . . 0.0 110.65 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 110.635 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 33.7 t -53.67 -43.97 69.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.341 -0.849 . . . . 0.0 111.134 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -69.08 -38.86 79.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.942 -1.099 . . . . 0.0 110.313 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.59 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -56.78 -50.25 72.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.958 -179.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -75.53 -38.99 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.057 -1.027 . . . . 0.0 111.179 -179.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -57.75 -48.26 80.13 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.998 -1.063 . . . . 0.0 111.195 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -70.49 -31.12 68.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.338 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.4 67.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -0.838 . . . . 0.0 111.072 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 37' ' ' ILE . 34.6 m -69.94 -35.5 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.36 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -66.38 -43.67 85.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . -67.77 -48.36 66.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.727 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' B' ' 44' ' ' TYR . 15.0 m-85 -61.7 -41.66 97.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.539 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 41' ' ' VAL . 73.0 mt -68.82 -26.01 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.24 -40.36 71.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.71 91.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.913 . . . . 0.0 110.156 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -25.5 64.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.78 84.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 51' ' ' GLU . 56.3 t -63.84 -37.93 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.29 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.96 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.331 0.586 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -112.73 114.28 26.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.067 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 40.3 p -69.14 141.03 54.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 110.25 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 2.1 t -97.92 149.66 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.4 -0.813 . . . . 0.0 109.558 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -99.27 129.19 45.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.555 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.23 115.12 21.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.891 -1.13 . . . . 0.0 111.462 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 7' ' ' ASN . 3.1 m-20 -100.67 117.17 34.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.478 HG13 HG13 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -137.77 153.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.661 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -97.84 123.85 41.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 110.92 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.674 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.5 m -138.8 164.4 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 1.035 ' O ' HG22 ' B' ' 14' ' ' VAL . 5.1 t -76.29 128.42 82.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.047 -1.033 . . . . 0.0 109.83 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 4' ' ' VAL . 47.2 Cg_endo -47.04 -8.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 123.721 1.38 . . . . 0.0 111.228 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' B' ' 11' ' ' SER . 1.0 OUTLIER -73.11 -27.04 61.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.072 -1.017 . . . . 0.0 110.195 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 1.035 HG22 ' O ' ' B' ' 11' ' ' SER . 1.3 m -75.63 -35.93 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.822 . . . . 0.0 110.646 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' CZ ' ' B' ' 19' ' ' ARG . 27.4 t0 -65.96 -49.45 67.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -59.31 -41.31 88.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.442 ' OG ' HD13 ' A' ' 45' ' ' LEU . 41.0 t -64.13 -40.01 95.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.01 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' B' ' 33' ' ' LEU . 2.4 t -58.96 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 110.157 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 22' ' ' ILE . 18.4 mtt-85 -60.9 -42.92 98.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 109.309 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -63.66 -43.23 97.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' B' ' 36' ' ' PHE . 0.7 OUTLIER -59.46 -51.22 70.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 110.886 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 19' ' ' ARG . 1.9 pp -60.14 -38.96 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.958 -1.089 . . . . 0.0 109.875 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.578 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -56.1 -27.96 55.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.977 . . . . 0.0 109.54 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.88 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' B' ' 26' ' ' GLY . 20.0 mm100 -94.89 8.43 42.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' B' ' 25' ' ' GLN . . . -40.92 150.1 0.17 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.29 112.74 3.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 -155.42 16.15 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -61.09 171.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -1.151 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' B' ' 31' ' ' GLY . 4.4 mmmt -61.68 -56.03 24.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.463 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' B' ' 30' ' ' LYS . . . 63.81 127.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.69 -161.84 1.04 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -68.56 -44.67 73.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.629 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' B' ' 38' ' ' GLU . 29.4 t -53.76 -43.85 69.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.227 -0.921 . . . . 0.0 111.197 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -69.16 -38.94 79.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.92 -1.112 . . . . 0.0 110.333 -179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.591 ' N ' ' HG3' ' B' ' 35' ' ' ARG . 0.1 OUTLIER -56.79 -50.11 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 111.027 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.513 ' O ' HG22 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -75.58 -39.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.031 -1.043 . . . . 0.0 111.225 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' B' ' 34' ' ' SER . 0.4 OUTLIER -57.74 -48.1 80.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.977 -1.077 . . . . 0.0 111.235 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.61 -31.19 68.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.346 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.07 -46.42 67.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 111.046 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.513 HG22 ' O ' ' B' ' 37' ' ' ILE . 34.9 m -69.91 -35.39 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 110.378 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' B' ' 43' ' ' ALA . 0.0 OUTLIER -66.46 -43.69 84.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' B' ' 42' ' ' ARG . . . -67.76 -48.3 66.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.783 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.706 ' CZ ' ' CZ ' ' A' ' 44' ' ' TYR . 15.6 m-85 -61.92 -41.4 97.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.558 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.453 HD12 ' O ' ' B' ' 41' ' ' VAL . 73.7 mt -68.96 -25.88 64.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 0.0 110.224 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.3 -40.45 70.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -38.51 91.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -0.974 . . . . 0.0 110.094 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -25.67 64.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.81 -45.5 85.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' B' ' 51' ' ' GLU . 53.1 t -64.3 -38.88 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' B' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.967 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 8.5 p30 -112.14 115.76 29.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.288 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p -74.78 145.97 42.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.97 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 21.9 t -100.19 149.04 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.93 . . . . 0.0 109.986 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.18 133.96 46.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 109.391 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.06 ' CH2' HD23 ' B' ' 33' ' ' LEU . 0.1 OUTLIER -130.73 113.98 14.8 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.345 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' TRP . 0.8 OUTLIER -107.12 122.47 46.55 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 109.067 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 34' ' ' SER . 0.1 OUTLIER -139.15 167.44 20.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.51 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 4' ' ' VAL . . . -96.64 118.83 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.936 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' B' ' 4' ' ' VAL . 20.6 m -138.74 165.14 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.354 -0.841 . . . . 0.0 109.991 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -76.39 146.06 77.0 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.069 -1.019 . . . . 0.0 110.08 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.79 -9.74 24.06 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.948 1.499 . . . . 0.0 110.148 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.29 -25.14 61.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.974 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.8 m -74.21 -31.8 30.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.629 -0.67 . . . . 0.0 110.747 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.21 -48.67 72.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 0.0 110.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.36 -42.8 96.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.46 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.471 ' OG ' HD22 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -64.34 -41.87 96.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 110.238 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 14' ' ' VAL . 58.8 t -59.58 -38.89 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.741 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.83 -44.2 93.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.2 mmm -63.86 -42.55 97.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.96 . . . . 0.0 109.985 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.61 -50.87 71.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.22 -0.925 . . . . 0.0 111.397 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -61.69 -36.34 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 110.065 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.39 -30.57 65.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.977 . . . . 0.0 109.548 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.4 60.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.788 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 10.2 tp-100 -88.17 0.25 56.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.75 -116.7 0.43 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.36 39.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.66 -175.62 22.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -77.5 -22.31 51.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -1.141 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -46.88 126.65 9.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.95 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.94 137.65 1.1 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -118.09 -158.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -1.208 . . . . 0.0 110.278 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.054 HD23 ' CH2' ' B' ' 6' ' ' TRP . 1.5 mp -68.15 -37.4 80.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.214 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.672 ' HA ' HD12 ' B' ' 8' ' ' ILE . 90.4 p -54.72 -34.5 62.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -39.89 74.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.119 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' B' ' 41' ' ' VAL . 2.0 t80 -56.24 -48.03 77.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' B' ' 37' ' ' ILE . 1.2 tt -72.93 -38.58 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.009 -1.057 . . . . 0.0 110.442 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 37' ' ' ILE . 2.0 tm-20 -57.16 -48.42 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 110.949 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.31 -31.85 69.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.97 . . . . 0.0 110.101 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.29 79.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -0.827 . . . . 0.0 110.523 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' B' ' 36' ' ' PHE . 24.0 m -72.31 -35.42 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.349 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -60.07 -39.48 86.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 110.347 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.96 -38.66 86.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.477 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 m-85 -68.75 -45.71 70.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.095 -1.003 . . . . 0.0 110.463 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' B' ' 17' ' ' SER . 6.5 mt -69.1 -25.75 64.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.439 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -74.08 -44.96 52.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 16.2 pt-20 -60.62 -42.2 96.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.01 -1.056 . . . . 0.0 110.448 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.17 54.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.163 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.87 89.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.988 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 51' ' ' GLU . 2.1 t -66.76 -47.15 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.958 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.247 0.546 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' B' ' 2' ' ' ASN . 8.5 p30 -112.19 116.14 29.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 68.5 p -75.12 145.28 42.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 21.5 t -99.55 149.07 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.939 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 ttp-105 -102.28 133.98 46.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 1.054 ' CH2' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.64 113.87 14.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.392 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -107.01 122.43 46.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.375 -0.828 . . . . 0.0 109.087 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -139.11 167.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.561 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 4' ' ' VAL . . . -96.75 118.96 34.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.877 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 19.8 m -138.86 165.02 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.845 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.741 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -76.28 145.84 77.03 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 0.0 110.088 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.64 -9.51 22.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.978 1.515 . . . . 0.0 110.189 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 -25.28 61.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.389 -0.819 . . . . 0.0 109.459 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.968 ' O ' HG23 ' B' ' 18' ' ' VAL . 2.8 m -74.18 -31.96 30.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.681 -0.637 . . . . 0.0 110.775 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.05 -48.69 72.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.058 -1.026 . . . . 0.0 110.219 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.27 -42.96 96.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 0.0 110.423 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -64.39 -41.7 96.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 0.0 110.246 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.968 HG23 ' O ' ' B' ' 14' ' ' VAL . 59.3 t -59.79 -38.85 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.274 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.749 ' O ' HG13 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -63.79 -44.3 93.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 109.867 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' MET . . . . . . . . . . . . . 10.1 mmm -63.7 -42.54 97.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.002 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.59 -51.0 71.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.369 -0.832 . . . . 0.0 111.36 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.749 HG13 ' O ' ' B' ' 19' ' ' ARG . 0.7 OUTLIER -61.45 -36.43 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 110.1 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.59 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.007 . . . . 0.0 109.512 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -32.4 59.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 109.821 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' B' ' 25' ' ' GLN . 10.2 tp-100 -88.23 0.37 56.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.7 -116.67 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.27 39.26 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.67 -175.6 22.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -77.53 -22.29 51.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -1.174 . . . . 0.0 110.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -46.84 126.35 8.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 137.71 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' B' ' 32' ' ' ASP . 0.0 OUTLIER -118.13 -158.88 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 1.06 HD23 ' CH2' ' A' ' 6' ' ' TRP . 1.4 mp -67.98 -37.44 81.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' SER . . . . . 0.674 ' HA ' HD12 ' A' ' 8' ' ' ILE . 90.3 p -54.67 -34.77 62.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.06 -39.73 75.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.49 ' CZ ' HG12 ' A' ' 41' ' ' VAL . 2.0 t80 -56.3 -48.02 77.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 110.45 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 37' ' ' ILE . 1.1 tt -72.95 -38.43 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.022 . . . . 0.0 110.514 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . 0.494 ' N ' HG23 ' B' ' 37' ' ' ILE . 2.0 tm-20 -57.17 -48.49 78.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.942 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.31 -31.66 69.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.171 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.35 79.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.527 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 23.8 m -72.25 -35.28 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.461 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.464 ' N ' HG23 ' B' ' 41' ' ' VAL . 0.0 OUTLIER -60.34 -39.07 85.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.264 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.32 -38.32 84.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' TYR . . . . . 0.616 ' O ' ' HG2' ' B' ' 47' ' ' GLU . 6.3 m-85 -69.05 -45.84 69.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.471 HD22 ' OG ' ' A' ' 17' ' ' SER . 6.3 mt -68.86 -25.75 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.079 -1.013 . . . . 0.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.15 -45.22 50.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 110.992 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' B' ' 44' ' ' TYR . 15.6 pt-20 -60.55 -42.25 96.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.522 ' N ' ' CG ' ' B' ' 47' ' ' GLU . 0.0 OUTLIER -77.47 -20.16 54.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.83 90.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' B' ' 51' ' ' GLU . 2.0 t -66.8 -46.63 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.403 -0.811 . . . . 0.0 109.984 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.53 ' HB3' HG12 ' B' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.147 179.859 . . . . . . . . 2 2 . 1 stop_ save_